-
1
-
-
33947489961
-
Isolation, structure and partial synthesis of an active constituent of hashish
-
Yechiel, G.; Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 1964, 86(8), 1646-1647
-
(1964)
J. Am. Chem. Soc.
, vol.86
, Issue.8
, pp. 1646-1647
-
-
Yechiel, G.1
Mechoulam, R.2
-
2
-
-
0344823856
-
Pain and cannabinoids: Science and evidence
-
Farquhar-Smith, W. P. Pain and cannabinoids: science and evidence. Pain Rev., 2002, 9, 41-67
-
(2002)
Pain Rev.
, vol.9
, pp. 41-67
-
-
Farquhar-Smith, W.P.1
-
3
-
-
18844400058
-
Cannabinoid-based drugs as anti-inflammatory therapy
-
Klein, T.W. Cannabinoid-based drugs as anti-inflammatory therapy. Nat. Rev. Immunol., 2005, 5, 400-411
-
(2005)
Nat. Rev. Immunol.
, vol.5
, pp. 400-411
-
-
Klein, T.W.1
-
4
-
-
1842611884
-
Cannabinoids and neuroinflammation
-
Walter, L.; Stella, N. Cannabinoids and neuroinflammation. B r. J. Pharmacol., 2004, 141, 75-785
-
(2004)
B R. J. Pharmacol.
, vol.141
, pp. 75-785
-
-
Walter, L.1
Stella, N.2
-
5
-
-
21344455919
-
Cannabinoids as potential anti-epileptic drugs
-
Smith, P.F. Cannabinoids as potential anti-epileptic drugs. Curr. Opin. Invest. Drugs, 2005, 6, 680-685
-
(2005)
Curr. Opin. Invest. Drugs
, vol.6
, pp. 680-685
-
-
Smith, P.F.1
-
6
-
-
33144480327
-
Cannabinoid receptors as therapeutic targets
-
Mackie, K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol., 2006, 46, 101-122
-
(2006)
Annu. Rev. Pharmacol. Toxicol.
, vol.46
, pp. 101-122
-
-
MacKie, K.1
-
7
-
-
33645796477
-
Cannabinoids
-
Pertwee Ed. Springer-Verlag: Heidelberg, Germany
-
Howlett, A.C. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed., Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 53-79
-
(2005)
Handbook of Experimental Pharmacology
, vol.168
, pp. 53-79
-
-
Howlett, A.C.1
-
8
-
-
18444376760
-
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
-
Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; Mechoulam, R.; Pertwee, R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 2002, 54, 161-202
-
(2002)
Pharmacol. Rev.
, vol.54
, pp. 161-202
-
-
Howlett, A.C.1
Barth, F.2
Bonner, T.I.3
Cabral, G.4
Casellas, P.5
Devane, W.A.6
Felder, C.C.7
Herkenham, M.8
MacKie, K.9
Martin, B.R.10
Mechoulam, R.11
Pertwee, R.G.12
-
9
-
-
0027078685
-
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
-
Devane, W.A.; Hanus, L.; Breuer, A.; Pertwee, R.G.; Stevenson, L.A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 1992, 258(5090), 1946-1949
-
(1992)
Science
, vol.258
, Issue.5090
, pp. 1946-1949
-
-
Devane, W.A.1
Hanus, L.2
Breuer, A.3
Pertwee, R.G.4
Stevenson, L.A.5
Griffin, G.6
Gibson, D.7
Mandelbaum, A.8
Etinger, A.9
Mechoulam, R.10
-
10
-
-
0029012014
-
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
-
Mechoulam, R.; Ben-Shabat, S.; Hanus, L.; Ligumsky, M.; Kaminski, N.E.; Schatz, A.R.; Gopher, A.; Almog, S.; Martin, B.R.; Compton, D.R.; Pertwee, R.G.; Griffin, G.; Bayewitch, M.; Barg, J.; Vogal, Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol, 1995, 50(1), 83-90
-
(1995)
Biochem. Pharmacol
, vol.50
, Issue.1
, pp. 83-90
-
-
Mechoulam, R.1
Ben-Shabat, S.2
Hanus, L.3
Ligumsky, M.4
Kaminski, N.E.5
Schatz, A.R.6
Gopher, A.7
Almog, S.8
Martin, B.R.9
Compton, D.R.10
Pertwee, R.G.11
Griffin, G.12
Bayewitch, M.13
Barg, J.14
Vogal, Z.15
-
11
-
-
0028970517
-
2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
-
Sugiura, T.; Kondo, S.; Sukagawa, A.; Nakane, S.; Shinoda, A.; Itoh, K.; Yamashita, A.; Waku, K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 1995, 215(1), 89-97
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.215
, Issue.1
, pp. 89-97
-
-
Sugiura, T.1
Kondo, S.2
Sukagawa, A.3
Nakane, S.4
Shinoda, A.5
Itoh, K.6
Yamashita, A.7
Waku, K.8
-
12
-
-
33645794041
-
Cannabinoids
-
Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany
-
Di Marzo, V. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 147-185
-
(2005)
Handbook of Experimental Pharmacology
, vol.168
, pp. 147-185
-
-
Di Marzo, V.1
-
13
-
-
33644804271
-
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
-
Pertwee, R.G. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J., 2005, 7, E625-E654
-
(2005)
AAPS J.
, vol.7
-
-
Pertwee, R.G.1
-
14
-
-
4644372326
-
The endogenous cannabinoid system and its role in nociceptive behavior
-
Cravatt, B.F.; Lichtman, A.H. The endogenous cannabinoid system and its role in nociceptive behavior. J. Neurobiol, 2004, 61(1), 149-160
-
(2004)
J. Neurobiol
, vol.61
, Issue.1
, pp. 149-160
-
-
Cravatt, B.F.1
Lichtman, A.H.2
-
15
-
-
0344441315
-
Cellular accumulation of anandamide: Consensus and controversy
-
Hillard, C.J.; Jarrahian, A. Cellular accumulation of anandamide: consensus and controversy. Br. J. Pharmacol, 2003, 140(5), 802-808
-
(2003)
Br. J. Pharmacol
, vol.140
, Issue.5
, pp. 802-808
-
-
Hillard, C.J.1
Jarrahian, A.2
-
16
-
-
33645795765
-
Cannabinoids
-
Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany
-
Vaughan, C.W.; Christie, M.J. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 367-383
-
(2005)
Handbook of Experimental Pharmacology
, vol.168
, pp. 367-383
-
-
Vaughan, C.W.1
Christie, M.J.2
-
17
-
-
84859047666
-
Cannabinoids
-
Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany
-
Cabral, G.A.; Staab, A. In: Cannabinoids. Handbook of Experimental Pharmacology; Pertwee, Ed.; Springer-Verlag: Heidelberg, Germany, 2005; Vol. 168, pp. 385-423
-
(2005)
Handbook of Experimental Pharmacology
, vol.168
, pp. 385-423
-
-
Cabral, G.A.1
Staab, A.2
-
18
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
Munro, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, 346, 561-564
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Munro, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
Young, A.C.4
Bonner, T.I.5
-
19
-
-
0033545866
-
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
-
Zimmer, A.; Zimmer, A.M.; Hohmann, A.G.; Herkenham, M.; Bonner, T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U S A., 1999, 96(10), 5780-5785
-
(1999)
Proc. Natl. Acad. Sci. U S A.
, vol.96
, Issue.10
, pp. 5780-5785
-
-
Zimmer, A.1
Zimmer, A.M.2
Hohmann, A.G.3
Herkenham, M.4
Bonner, T.I.5
-
20
-
-
0029094470
-
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
-
Galiègue, S.; Mary, S.; Marchand, J.; Dussossoy, D.; Carrière, D.; Carayon, P.; Bouaboula, M.; Shire, D.; Le Fur, G.; Casellas, P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem., 1995, 232(1), 54-61
-
(1995)
Eur. J. Biochem.
, vol.232
, Issue.1
, pp. 54-61
-
-
Galiègue, S.1
Mary, S.2
Marchand, J.3
Dussossoy, D.4
Carrière, D.5
Carayon, P.6
Bouaboula, M.7
Shire, D.8
Le Fur, G.9
Casellas, P.10
-
21
-
-
53549119424
-
An endocannabinoid hypothesis of drug reward and drug addiction
-
Onaivi, E.S. An endocannabinoid hypothesis of drug reward and drug addiction. Ann. N Y. Acad. Sci., 2008, 1139, 412-421
-
(2008)
Ann. N Y. Acad. Sci.
, vol.1139
, pp. 412-421
-
-
Onaivi, E.S.1
-
22
-
-
33748703859
-
The endocannabinoid system as an emerging target of pharmacotherapy
-
Pacher, P.; Bátkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58(3), 389-462
-
(2006)
Pharmacol. Rev.
, vol.58
, Issue.3
, pp. 389-462
-
-
Pacher, P.1
Bátkai, S.2
Kunos, G.3
-
23
-
-
42349116262
-
Cannabinoid receptors: Where they are and what they do
-
Mackie, K. Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol, 2008, 20, 10-14
-
(2008)
J. Neuroendocrinol
, vol.20
, pp. 10-14
-
-
MacKie, K.1
-
24
-
-
58149138840
-
Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain?
-
Kunos, G.; Osei-Hyiaman, D.; Bátkai, S.; Sharkey, K.A.; Makriyannis, A. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? Trends Pharmacol. Sci., 2009, 30(1), 1-7
-
(2009)
Trends Pharmacol. Sci.
, vol.30
, Issue.1
, pp. 1-7
-
-
Kunos, G.1
Osei-Hyiaman, D.2
Bátkai, S.3
Sharkey, K.A.4
Makriyannis, A.5
-
25
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61-65
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.L.2
Abu-Shaar, M.3
-
26
-
-
26844504226
-
Identification and functional characterization of brainstem cannabinoid CB2 receptors
-
Van Sickle, M.D.; Duncan, M.; Kingsley, P.J.; Mouihate, A.; Urbani, P.; Mackie, K.; Stella, N.; Makriyannis, A.; Piomelli, D.; Davison, J.S.; Marnett, L.J.; Di Marzo, V; Pittman, Q.J.; Patel, K.D.; Sharkey, K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 2005, 310, 329-332
-
(2005)
Science
, vol.310
, pp. 329-332
-
-
Van Sickle, M.D.1
Duncan, M.2
Kingsley, P.J.3
Mouihate, A.4
Urbani, P.5
MacKie, K.6
Stella, N.7
Makriyannis, A.8
Piomelli, D.9
Davison, J.S.10
Marnett, L.J.11
Di Marzo, V.12
Pittman, Q.J.13
Patel, K.D.14
Sharkey, K.A.15
-
27
-
-
33244493807
-
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
-
Ashton, J.C.; Friberg, D.; Darlington, C.L.; Smith, PF. Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study. Neurosci. Lett, 2006, 396(2), 113-116
-
(2006)
Neurosci. Lett
, vol.396
, Issue.2
, pp. 113-116
-
-
Ashton, J.C.1
Friberg, D.2
Darlington, C.L.3
Smith, P.F.4
-
28
-
-
32844465920
-
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
-
Gong, J.P; Onaivi, E.S.; Ishiguro, H.; Liu, Q.R.; Tagliaferro, P.A.; Brusco, A.; Uhl, G.R. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res., 2006, 1071(1), 10-23
-
(2006)
Brain Res.
, vol.1071
, Issue.1
, pp. 10-23
-
-
Gong, J.P.1
Onaivi, E.S.2
Ishiguro, H.3
Liu, Q.R.4
Tagliaferro, P.A.5
Brusco, A.6
Uhl, G.R.7
-
29
-
-
63049105150
-
Emerging role of the cannabinoid receptor CB2 in immune regulation: Therapeutic prospects for neuroinflammation
-
Cabral, G.A.; Griffin-Thomas, L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert. Rev. Mol Med., 2009, 11, e3
-
(2009)
Expert. Rev. Mol Med.
, vol.11
-
-
Cabral, G.A.1
Griffin-Thomas, L.2
-
30
-
-
38349119715
-
Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain
-
Guindon, J.; Hohmann, A.G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharmacol, 2008, 153, 319-334
-
(2008)
Br. J. Pharmacol
, vol.153
, pp. 319-334
-
-
Guindon, J.1
Hohmann, A.G.2
-
31
-
-
2542572598
-
Development of a 3D Model for the Human Cannabinoid CB1 Receptor
-
Salo, O.M.H.; Lahtela-Kakkonen, M.; Gynther, J.; Järvinen, T.; Poso, A. Development of a 3D Model for the Human Cannabinoid CB1 Receptor. J. Med. Chem., 2004, 47, 3048-3057.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 3048-3057
-
-
Salo, O.M.H.1
Lahtela-Kakkonen, M.2
Gynther, J.3
Järvinen, T.4
Poso, A.5
-
32
-
-
0034604451
-
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
-
Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, CA.; Motoshima, H.; Fox, B.A.; Le Trong, I; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor. Science, 2000, 289(5480), 739-745
-
(2000)
Science
, vol.289
, Issue.5480
, pp. 739-745
-
-
Palczewski, K.1
Kumasaka, T.2
Hori, T.3
Behnke, C.A.4
Motoshima, H.5
Fox, B.A.6
Le Trong, I.7
Teller, D.C.8
Okada, T.9
Stenkamp, R.E.10
Yamamoto, M.11
Miyano, M.12
-
33
-
-
80255139280
-
2AR
-
2AR. J. Mol Model, 2011, 17, 2353-2366
-
(2011)
J. Mol Model
, vol.17
, pp. 2353-2366
-
-
Latek, D.1
Kolinski, M.2
Ghoshdastider, U.3
Debinski, A.4
Bombolewski, R.5
Plazinska, A.6
Jozwiak, K.7
Filipek, S.8
-
34
-
-
77957273334
-
Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery
-
Shim, J.-Y Understanding Functional Residues of the Cannabinoid CB1 Receptor for Drug Discovery. Curr. Top. Med. Chem., 2010, 10(8), 779-798
-
(2010)
Curr. Top. Med. Chem.
, vol.10
, Issue.8
, pp. 779-798
-
-
Shim, J.-Y.1
-
35
-
-
80052930474
-
2 receptor
-
2 receptor. Eur. J. Med. Chem., 2011, 46, 4489-4505
-
(2011)
Eur. J. Med. Chem.
, vol.46
, pp. 4489-4505
-
-
Cichero, E.1
Ligresti, A.2
Allarà, M.3
Di Marzo, V.4
Lazzati, Z.5
D'Ursi, P.6
Marabotti, A.7
Milanesi, L.8
Spallarossa, A.9
Ranise, A.10
Fossa, P.11
-
36
-
-
12844283365
-
The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism
-
Choi, G.; Guo, J.; Makriyannis, A. The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism. Biochim. Biophys. Acta., 2005, 1668(1), 1-9
-
(2005)
Biochim. Biophys. Acta.
, vol.1668
, Issue.1
, pp. 1-9
-
-
Choi, G.1
Guo, J.2
Makriyannis, A.3
-
37
-
-
65249115932
-
Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes
-
Tiburu, E.K.; Bowman, A.L.; Struppe, J.O.; Janero, D.R.; Avraham, H.K.; Makriyannis, A. Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes. Biochim. Biophys. Acta., 2009, 1788(5), 1159-1167
-
(2009)
Biochim. Biophys. Acta.
, vol.1788
, Issue.5
, pp. 1159-1167
-
-
Tiburu, E.K.1
Bowman, A.L.2
Struppe, J.O.3
Janero, D.R.4
Avraham, H.K.5
Makriyannis, A.6
-
38
-
-
13544267409
-
NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles
-
Xie, X.Q.; Chen, J.Z. NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles. J. Biol. Chem., 2005, 280(5), 3605-3612
-
(2005)
J. Biol. Chem.
, vol.280
, Issue.5
, pp. 3605-3612
-
-
Xie, X.Q.1
Chen, J.Z.2
-
39
-
-
33646413423
-
NMR characterization of recombinant transmembrane protein CB2 fragment CB2(180-233)
-
Zhao, J.; Zheng, H.; Xie, X.Q. NMR characterization of recombinant transmembrane protein CB2 fragment CB2(180-233). Protein Pept. Lett., 2006, 13(4), 335-342
-
(2006)
Protein Pept. Lett.
, vol.13
, Issue.4
, pp. 335-342
-
-
Zhao, J.1
Zheng, H.2
Xie, X.Q.3
-
40
-
-
42749091750
-
Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326))
-
Zhang, Y.; Xie, X.Q. Biosynthesis, purification, and characterization of a cannabinoid receptor 2 fragment (CB2(271-326)). Protein Expr. Purif., 2008, 59(2), 249-257
-
(2008)
Protein Expr. Purif.
, vol.59
, Issue.2
, pp. 249-257
-
-
Zhang, Y.1
Xie, X.Q.2
-
41
-
-
0036729440
-
The cytoplasmic helix of cannabinoid receptor CB2, a conformational study by circular dichroism and (1)H NMR spectroscopy in aqueous and membrane-like environments
-
Choi, G.; Landin, J.; Xie, X.Q. The cytoplasmic helix of cannabinoid receptor CB2, a conformational study by circular dichroism and (1)H NMR spectroscopy in aqueous and membrane-like environments. J. Pept. Res., 2002, 60(3), 169-177
-
(2002)
J. Pept. Res.
, vol.60
, Issue.3
, pp. 169-177
-
-
Choi, G.1
Landin, J.2
Xie, X.Q.3
-
42
-
-
33748363914
-
A transmembrane helix-bundle from G-protein coupled receptor CB2: Biosynthesis, purification, and NMR characterization
-
Zheng, H.; Zhao, J.; Sheng, W.; Xie, X.Q. A transmembrane helix-bundle from G-protein coupled receptor CB2: biosynthesis, purification, and NMR characterization. Biopolymers., 2006, 83(1), 46-61
-
(2006)
Biopolymers.
, vol.83
, Issue.1
, pp. 46-61
-
-
Zheng, H.1
Zhao, J.2
Sheng, W.3
Xie, X.Q.4
-
43
-
-
0029956258
-
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
-
Shire, D.; Calandra, B.; Rinaldi-Carmona, M.; Oustric, D.; Pessègue, B.; Bonnin-Cabanne, O.; Le Fur, G.; Caput, D.; Ferrara, P. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim. Biophys. Acta., 1996, 1307(2), 132-136
-
(1996)
Biochim. Biophys. Acta.
, vol.1307
, Issue.2
, pp. 132-136
-
-
Shire, D.1
Calandra, B.2
Rinaldi-Carmona, M.3
Oustric, D.4
Pessègue, B.5
Bonnin-Cabanne, O.6
Le Fur, G.7
Caput, D.8
Ferrara, P.9
-
44
-
-
32344446060
-
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis
-
Tuccinardi, T.; Ferrarini, P.L.; Manera, C.; Ortore, G.; Saccomanni, G.; Martinelli, A. Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis. J. Med. Chem., 2006, 49(3), 984-994
-
(2006)
J. Med. Chem.
, vol.49
, Issue.3
, pp. 984-994
-
-
Tuccinardi, T.1
Ferrarini, P.L.2
Manera, C.3
Ortore, G.4
Saccomanni, G.5
Martinelli, A.6
-
45
-
-
18144385088
-
Evidence for novel cannabinoid receptors
-
Begg, M.; Pacher, P.; Bátkai, S.; Osei-Hyiaman, D.; Offertáler, L.; Mo, F.M.; Liu, J.; Kunos, G. Evidence for novel cannabinoid receptors. Pharmacol. Ther., 2005, 106, 133-145
-
(2005)
Pharmacol. Ther.
, vol.106
, pp. 133-145
-
-
Begg, M.1
Pacher, P.2
Bátkai, S.3
Osei-Hyiaman, D.4
Offertáler, L.5
Mo, F.M.6
Liu, J.7
Kunos, G.8
-
46
-
-
0033769188
-
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain
-
Di Marzo, V.; Breivogel, C.S.; Tao, Q.; Bridgen, D.T.; Razdan, R.K.; Zimmer, A.M.; Zimmer, A.; Martin, B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem., 2000, 75, 2434-2444
-
(2000)
J. Neurochem.
, vol.75
, pp. 2434-2444
-
-
Di Marzo, V.1
Breivogel, C.S.2
Tao, Q.3
Bridgen, D.T.4
Razdan, R.K.5
Zimmer, A.M.6
Zimmer, A.7
Martin, B.R.8
-
47
-
-
0035801320
-
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
-
Hajos, N.; Ledent, C.; Freund, T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience, 2001, 106, 1-4
-
(2001)
Neuroscience
, vol.106
, pp. 1-4
-
-
Hajos, N.1
Ledent, C.2
Freund, T.F.3
-
48
-
-
0036297517
-
Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice
-
Monory, K.; Tzavara, E.T.; Lexime, J.; Ledent, C.; Parmentier, M.; Borsodi, A.; Hanoune, J. Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochem. Biophys. Res. Commun., 2002, 292, 231-235
-
(2002)
Biochem. Biophys. Res. Commun.
, vol.292
, pp. 231-235
-
-
Monory, K.1
Tzavara, E.T.2
Lexime, J.3
Ledent, C.4
Parmentier, M.5
Borsodi, A.6
Hanoune, J.7
-
49
-
-
0038845604
-
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
-
Jarai, Z.; Wagner, J.A.; Varga, K.; Lake, K.D.; Compton, D.R.; Martin, B.R.; Zimmer, A.M.; Bonner, T.I.; Buckley, N.E.; Mezey, E.; Razdan, R.K.; Zimmer, A.; Kunos, G. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. USA, 1999, 96, 14136-14141
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 14136-14141
-
-
Jarai, Z.1
Wagner, J.A.2
Varga, K.3
Lake, K.D.4
Compton, D.R.5
Martin, B.R.6
Zimmer, A.M.7
Bonner, T.I.8
Buckley, N.E.9
Mezey, E.10
Razdan, R.K.11
Zimmer, A.12
Kunos, G.13
-
50
-
-
0038561226
-
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery
-
Ho, W.S.; Hiley, C.R. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. B r. J. Pharmacol., 2003, 138, 1320-332
-
(2003)
B R. J. Pharmacol.
, vol.138
, pp. 1320-1332
-
-
Ho, W.S.1
Hiley, C.R.2
-
51
-
-
0042934012
-
Evidence for cannabinoid receptor-dependent and-independent mechanisms of action in leukocytes
-
Kaplan, B.L.; Rockwell, C.E.; Kaminski, N.E. Evidence for cannabinoid receptor-dependent and-independent mechanisms of action in leukocytes. J. Pharmacol. Exp. Ther., 2003, 306, 1077-1085
-
(2003)
J. Pharmacol. Exp. Ther.
, vol.306
, pp. 1077-1085
-
-
Kaplan, B.L.1
Rockwell, C.E.2
Kaminski, N.E.3
-
52
-
-
35649015179
-
The orphan receptor GPR55 is a novel cannabinoid receptor
-
Ryberg, E.; Larsson, N.; Sjögren, S.; Hjorth, S.; Hermansson, N.O.; Leonova, J.; Elebring, T.; Nilsson, K.; Drmota, T.; Greasley, P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. B r. J. Pharmacol., 2007, 152(7), 1092-1101
-
(2007)
B R. J. Pharmacol.
, vol.152
, Issue.7
, pp. 1092-1101
-
-
Ryberg, E.1
Larsson, N.2
Sjögren, S.3
Hjorth, S.4
Hermansson, N.O.5
Leonova, J.6
Elebring, T.7
Nilsson, K.8
Drmota, T.9
Greasley, P.J.10
-
53
-
-
2542555018
-
The complexities of the cardiovascular actions of cannabinoids
-
Randall, M.D.; Kendall, D.A.; O'Sullivan, S. The complexities of the cardiovascular actions of cannabinoids. Br. J. Pharmacol., 2004, 142, 20-26
-
(2004)
Br. J. Pharmacol.
, vol.142
, pp. 20-26
-
-
Randall, M.D.1
Kendall, D.A.2
O'Sullivan, S.3
-
54
-
-
0032924113
-
Mesenteric vasodilation mediated by endothelial anandamide receptors
-
Wagner, J.A.; Varga, K.; Jarai, Z.; Kunos, G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 1999, 33, 429-434
-
(1999)
Hypertension
, vol.33
, pp. 429-434
-
-
Wagner, J.A.1
Varga, K.2
Jarai, Z.3
Kunos, G.4
-
55
-
-
0242584643
-
Selective ligands and cellular effectors of a G proteincoupled endothelial cannabinoid receptor
-
Offertáler, L.; Mo, F.M.; Bátkai, S.; Liu, J.; Begg, M.; Razdan, R.K.; Martin, B.R.; Bukoski, R.D.; Kunos, G. Selective ligands and cellular effectors of a G proteincoupled endothelial cannabinoid receptor. Mol. Pharm., 2003, 63, 699-705
-
(2003)
Mol. Pharm.
, vol.63
, pp. 699-705
-
-
Offertáler, L.1
Mo, F.M.2
Bátkai, S.3
Liu, J.4
Begg, M.5
Razdan, R.K.6
Martin, B.R.7
Bukoski, R.D.8
Kunos, G.9
-
56
-
-
0017667130
-
A cannabinoid with cardiovascular activity but no overt behavioral effects
-
Adams, M.D.; Earnhardt, J.T.; Martin, B.R.; Harris, L.S.; Dewey, W.L.; Razdan, R.K. A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia, 1977, 33, 1204-1205
-
(1977)
Experientia
, vol.33
, pp. 1204-1205
-
-
Adams, M.D.1
Earnhardt, J.T.2
Martin, B.R.3
Harris, L.S.4
Dewey, W.L.5
Razdan, R.K.6
-
57
-
-
35648959293
-
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
-
Johns, D.G.; Behm, D.J.; Walker, D.J.; Ao, Z.; Shapland, E.M.; Daniels, D.A.; Riddick, M.; Dowell, S.; Staton, P.C.; Green, P.; Shabon, U.; Bao, W.; Aiyar, N.; Yue, T.L.; Brown, A.J.; Morrison, A.D.; Douglas, S.A. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. B r. J. Pharmacol., 2007, 152(5), 825-831
-
(2007)
B R. J. Pharmacol.
, vol.152
, Issue.5
, pp. 825-831
-
-
Johns, D.G.1
Behm, D.J.2
Walker, D.J.3
Ao, Z.4
Shapland, E.M.5
Daniels, D.A.6
Riddick, M.7
Dowell, S.8
Staton, P.C.9
Green, P.10
Shabon, U.11
Bao, W.12
Aiyar, N.13
Yue, T.L.14
Brown, A.J.15
Morrison, A.D.16
Douglas, S.A.17
-
58
-
-
30344476972
-
Silico patent searching reveals a new cannabinoid receptor
-
Baker, D.; Pryce, G.; Davies, W.L.; Hiley, C.R. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol. Sci., 2006, 27, 1-4
-
(2006)
Trends Pharmacol. Sci.
, vol.27
, pp. 1-4
-
-
Baker, D.1
Pryce, G.2
Davies, W.L.3
Hiley, C.R.4
-
59
-
-
0029118444
-
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
-
Felder, C.C.; Joyce, K.E.; Briley, E.M.; Mansouri, J.; Mackie, K.; Blond, O.; Lai, Y.; Ma, A.L.; Mitchell, R.L. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol., 1995, 48, 443-450
-
(1995)
Mol. Pharmacol.
, vol.48
, pp. 443-450
-
-
Felder, C.C.1
Joyce, K.E.2
Briley, E.M.3
Mansouri, J.4
MacKie, K.5
Blond, O.6
Lai, Y.7
Ma, A.L.8
Mitchell, R.L.9
-
60
-
-
34249933789
-
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion
-
Bifulco, M.; Laezza, C.; Gazzerro, P; Pentimalli, F. Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion. Oncol. Rep., 2007, 17, 813-816
-
(2007)
Oncol. Rep.
, vol.17
, pp. 813-816
-
-
Bifulco, M.1
Laezza, C.2
Gazzerro, P.3
Pentimalli, F.4
-
61
-
-
33749165439
-
Endocannabinoid overactivity and intestinal inflammation
-
Di Marzo, V.; Izzo, A.A. Endocannabinoid overactivity and intestinal inflammation. Gut, 2006, 55, 1373-1376
-
(2006)
Gut
, vol.55
, pp. 1373-1376
-
-
Di Marzo, V.1
Izzo, A.A.2
-
62
-
-
34250209535
-
Attenuation of allergic contact dermatitis through the endocannabinoid system
-
Karsak, M.; Gaffal, E.; Date, R.; Wang-Eckhardt, L.; Rehnelt, J.; Petrosino, S.; Starowicz, K.; Steuder, R.; Schlicker, E.; Cravatt, B.; Mechoulam, R.; Buettner, R.; Werner, S.; Di Marzo, V.; Tüting, T.; Zimmer, A. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science, 2007, 316, 1494-497
-
(2007)
Science
, vol.316
, pp. 1494-1497
-
-
Karsak, M.1
Gaffal, E.2
Date, R.3
Wang-Eckhardt, L.4
Rehnelt, J.5
Petrosino, S.6
Starowicz, K.7
Steuder, R.8
Schlicker, E.9
Cravatt, B.10
Mechoulam, R.11
Buettner, R.12
Werner, S.13
Di Marzo, V.14
Tüting, T.15
Zimmer, A.16
-
63
-
-
0033661798
-
Cannabinoid receptors and the regulation of immune response
-
Berdyshev, E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 2000, 108, 169-190
-
(2000)
Chem. Phys. Lipids
, vol.108
, pp. 169-190
-
-
Berdyshev, E.V.1
-
64
-
-
23244457833
-
Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing
-
Wright, K.; Rooney, N.; Feeney, M.; Tate, J.; Robertson, D.; Welham, M.; Ward, S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005, 129, 437-453
-
(2005)
Gastroenterology
, vol.129
, pp. 437-453
-
-
Wright, K.1
Rooney, N.2
Feeney, M.3
Tate, J.4
Robertson, D.5
Welham, M.6
Ward, S.7
-
65
-
-
34347393913
-
Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages
-
Mukhopadhyay, S.; Das, S.; Williams, E.A.; Moore, D.; Jones, J.D.; Zahm, D.S.; Ndengele, M.M.; Lechner, A.J.; Howlett, A.C. Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages. J. Neuroimmunol., 2006, 181(1-2), 82-92
-
(2006)
J. Neuroimmunol.
, vol.181
, Issue.1-2
, pp. 82-92
-
-
Mukhopadhyay, S.1
Das, S.2
Williams, E.A.3
Moore, D.4
Jones, J.D.5
Zahm, D.S.6
Ndengele, M.M.7
Lechner, A.J.8
Howlett, A.C.9
-
66
-
-
0034685707
-
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor
-
Buckley, N.E.; McCoy, K.L.; Mezey, E.; Bonner, T.; Zimmer, A.; Felder, C.C.; Glass, M.; Zimmer, A. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol., 2000, 396(2-3), 141-149
-
(2000)
Eur. J. Pharmacol.
, vol.396
, Issue.2-3
, pp. 141-149
-
-
Buckley, N.E.1
McCoy, K.L.2
Mezey, E.3
Bonner, T.4
Zimmer, A.5
Felder, C.C.6
Glass, M.7
Zimmer, A.8
-
67
-
-
0038678773
-
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
-
Klegeris, A.; Bissonnette, C.J.; McGeer, P.L. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. B r. J. Pharmacol., 2003, 139(4), 775-786
-
(2003)
B R. J. Pharmacol.
, vol.139
, Issue.4
, pp. 775-786
-
-
Klegeris, A.1
Bissonnette, C.J.2
McGeer, P.L.3
-
68
-
-
0037089221
-
Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol
-
Jordà, M.A.; Verbakel, S.E.; Valk, P.J.; Vankan-Berkhoudt, Y.V.; Maccarrone, M.; Finazzi-Agrò, A.; Löwenberg, B.; Delwel, R. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood, 2002, 99(8), 2786-2793
-
(2002)
Blood
, vol.99
, Issue.8
, pp. 2786-2793
-
-
Jordà, M.A.1
Verbakel, S.E.2
Valk, P.J.3
Vankan-Berkhoudt, Y.V.4
MacCarrone, M.5
Finazzi-Agrò, A.6
Löwenberg, B.7
Delwel, R.8
-
69
-
-
33847420442
-
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
-
Benito, C.; Romero, J.P.; Tolon, R.M.; Clemente, D.; Docagne, F.; Hillard, C.J.; Guaza, C.; Romero, J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J. Neurosci., 2007, 27(9), 2396-2402
-
(2007)
J. Neurosci.
, vol.27
, Issue.9
, pp. 2396-2402
-
-
Benito, C.1
Romero, J.P.2
Tolon, R.M.3
Clemente, D.4
Docagne, F.5
Hillard, C.J.6
Guaza, C.7
Romero, J.8
-
70
-
-
64249138218
-
The therapeutic potential of novel cannabinoid receptors
-
Kreitzer, F.R.; Stella, N. The therapeutic potential of novel cannabinoid receptors. Pharmacol. Ther., 2009, 122(2), 83-96
-
(2009)
Pharmacol. Ther.
, vol.122
, Issue.2
, pp. 83-96
-
-
Kreitzer, F.R.1
Stella, N.2
-
71
-
-
17444370570
-
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
-
Lastres-Becker, I.; Molina-Holgado, F.; Ramos, J.A.; Mechoulam, R.; Fernandez-Ruiz, J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol. Dis., 2005, 19(1-2), 96-107
-
(2005)
Neurobiol. Dis.
, vol.19
, Issue.1-2
, pp. 96-107
-
-
Lastres-Becker, I.1
Molina-Holgado, F.2
Ramos, J.A.3
Mechoulam, R.4
Fernandez-Ruiz, J.5
-
72
-
-
66449132820
-
WIN55, 212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease
-
Price, D.A.; Martinez, A.A.; Seillier, A.; Koek, W.; Acosta, Y.; Fernandez, E.; Strong, R.; Lutz, B.; Marsicano, G.; Roberts, J.L.; Giuffrida, A. WIN55, 212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease. Eur. J. Neurosci., 2009, 29(11), 2177-2186
-
(2009)
Eur. J. Neurosci.
, vol.29
, Issue.11
, pp. 2177-2186
-
-
Price, D.A.1
Martinez, A.A.2
Seillier, A.3
Koek, W.4
Acosta, Y.5
Fernandez, E.6
Strong, R.7
Lutz, B.8
Marsicano, G.9
Roberts, J.L.10
Giuffrida, A.11
-
73
-
-
33947278309
-
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
-
Shoemaker, J.L.; Seely, K.A.; Reed, R.L.; Crow, J.P.; Prather, P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem., 2007, 101(1), 87-98
-
(2007)
J. Neurochem.
, vol.101
, Issue.1
, pp. 87-98
-
-
Shoemaker, J.L.1
Seely, K.A.2
Reed, R.L.3
Crow, J.P.4
Prather, P.L.5
-
74
-
-
71449090224
-
Latest advances in cannabinoid receptor agonists
-
Thakur, G.A.; Tichkule, R.; Bajaj, S.; Makriyannis, A. Latest advances in cannabinoid receptor agonists. Expert. Opin. Ther. Pat., 2009, 19(12), 1647-1673
-
(2009)
Expert. Opin. Ther. Pat.
, vol.19
, Issue.12
, pp. 1647-1673
-
-
Thakur, G.A.1
Tichkule, R.2
Bajaj, S.3
Makriyannis, A.4
-
75
-
-
0348010292
-
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains
-
Benito, C.; Núñez, E.; Tolón, R.M.; Carrier, E.J.; Rábano, A.; Hillard, C.J.; Romero, J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci., 2003, 23(35), 11136-11141
-
(2003)
J. Neurosci.
, vol.23
, Issue.35
, pp. 11136-11141
-
-
Benito, C.1
Núñez, E.2
Tolón, R.M.3
Carrier, E.J.4
Rábano, A.5
Hillard, C.J.6
Romero, J.7
-
76
-
-
0035236738
-
Inflammation in Parkinson's disease
-
McGeer, P.L.; Yasojima, K.; McGeer, E.G. Inflammation in Parkinson's disease. Adv. Neurol., 2001, 86, 83-89
-
(2001)
Adv. Neurol.
, vol.86
, pp. 83-89
-
-
McGeer, P.L.1
Yasojima, K.2
McGeer, E.G.3
-
77
-
-
0035111235
-
Early and progressive accumulation of reactive microglia in the Huntington disease brain
-
Sapp, E.; Kegel, K.B.; Aronin, N.; Hashikawa, T.; Uchiyama, Y.; Tohyama, K.; Bhide, P.G.; Vonsattel, J.P.; DiFiglia, M. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol., 2001, 60(2), 161-172
-
(2001)
J. Neuropathol. Exp. Neurol.
, vol.60
, Issue.2
, pp. 161-172
-
-
Sapp, E.1
Kegel, K.B.2
Aronin, N.3
Hashikawa, T.4
Uchiyama, Y.5
Tohyama, K.6
Bhide, P.G.7
Vonsattel, J.P.8
Difiglia, M.9
-
78
-
-
0038240048
-
Inflammation in multiple sclerosis: The good, the bad, and the complex
-
Martino, G.; Adorini, L.; Rieckmann, P.; Hillert, J.; Kallmann, B.; Comi, G.; Filippi, M. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol., 2002, 1(8), 499-509
-
(2002)
Lancet Neurol.
, vol.1
, Issue.8
, pp. 499-509
-
-
Martino, G.1
Adorini, L.2
Rieckmann, P.3
Hillert, J.4
Kallmann, B.5
Comi, G.6
Filippi, M.7
-
79
-
-
0037440415
-
Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide
-
Facchinetti, F.; Del Giudice, E.; Furegato, S.; Passarotto, M.; Leon, A. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide. Glia, 2003, 41(2), 161-168
-
(2003)
Glia
, vol.41
, Issue.2
, pp. 161-168
-
-
Facchinetti, F.1
Del Giudice, E.2
Furegato, S.3
Passarotto, M.4
Leon, A.5
-
80
-
-
0038678773
-
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
-
Klegeris, A.; Bissonnette, C.J.; McGeer, P.L. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. B r. J. Pharmacol., 2003, 139(4), 775-786
-
(2003)
B R. J. Pharmacol.
, vol.139
, Issue.4
, pp. 775-786
-
-
Klegeris, A.1
Bissonnette, C.J.2
McGeer, P.L.3
-
81
-
-
0037085572
-
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures
-
Molina-Holgado, F.; Molina-Holgado, E.; Guaza, C.; Rothwell, N.J. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J. Neurosci. Res., 2002, 67(6), 829-836
-
(2002)
J. Neurosci. Res.
, vol.67
, Issue.6
, pp. 829-836
-
-
Molina-Holgado, F.1
Molina-Holgado, E.2
Guaza, C.3
Rothwell, N.J.4
-
82
-
-
13244283049
-
Synthetic cannabinoid WIN55, 212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes
-
Sheng, W.S.; Hu, S.; Min, X.; Cabral, G.A.; Lokensgard, J.R.; Peterson, P.K. Synthetic cannabinoid WIN55, 212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia, 2005, 49(2), 211-219
-
(2005)
Glia
, vol.49
, Issue.2
, pp. 211-219
-
-
Sheng, W.S.1
Hu, S.2
Min, X.3
Cabral, G.A.4
Lokensgard, J.R.5
Peterson, P.K.6
-
83
-
-
0033803432
-
The cannabinoid system and cytokine network
-
Klein, T.W.; Lane, B.; Newton, C.A.; Friedman, H. The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med., 2000, 225(1), 1-8
-
(2000)
Proc. Soc. Exp. Biol. Med.
, vol.225
, Issue.1
, pp. 1-8
-
-
Klein, T.W.1
Lane, B.2
Newton, C.A.3
Friedman, H.4
-
84
-
-
0041842648
-
Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia
-
Molina-Holgado, F.; Pinteaux, E.; Moore, J.D.; Molina-Holgado, E.; Guaza, C.; Gibson, R.M.; Rothwell, N.J. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J. Neurosci., 2003, 23(16), 6470-6474
-
(2003)
J. Neurosci.
, vol.23
, Issue.16
, pp. 6470-6474
-
-
Molina-Holgado, F.1
Pinteaux, E.2
Moore, J.D.3
Molina-Holgado, E.4
Guaza, C.5
Gibson, R.M.6
Rothwell, N.J.7
-
85
-
-
0035452419
-
Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
-
Berrendero, F.; Sanchez, A.; Cabranes, A.; Puerta, C.; Ramos, J.A.; Garcia-Merino, A.; Fernandez-Ruiz, J. Changes in cannabinoid CB (1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Synapse, 2001, 41(3), 195-202
-
(2001)
Synapse
, vol.41
, Issue.3
, pp. 195-202
-
-
Berrendero, F.1
Sanchez, A.2
Cabranes, A.3
Puerta, C.4
Ramos, J.A.5
Garcia-Merino, A.6
Fernandez-Ruiz, J.7
-
86
-
-
59049099828
-
A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by down-regulating adhesion molecules
-
Mestre, L.; Docagne, F.; Correa, F.; Loria, F.; Hernangomez, M.; Borrell, J.; Guaza, C. A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by down-regulating adhesion molecules. Mol. Cell. Neurosci., 2009, 40(2), 258-266
-
(2009)
Mol. Cell. Neurosci.
, vol.40
, Issue.2
, pp. 258-266
-
-
Mestre, L.1
Docagne, F.2
Correa, F.3
Loria, F.4
Hernangomez, M.5
Borrell, J.6
Guaza, C.7
-
87
-
-
34347397535
-
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
-
Ashton, J.C.; Glass, M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr. Neuropharmacol., 2007, 5(2), 73-80
-
(2007)
Curr. Neuropharmacol.
, vol.5
, Issue.2
, pp. 73-80
-
-
Ashton, J.C.1
Glass, M.2
-
88
-
-
53049094391
-
Cannabinoids as therapeutic agents for ablating neuroinflammatory disease
-
Cabral, G.A.; Griffin-Thomas, L. Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocr. Metab. Immune Disord. Drug Ta r g e t s, 2008, 8(3), 159-172
-
(2008)
Endocr. Metab. Immune Disord. Drug Ta R G e T S
, vol.8
, Issue.3
, pp. 159-172
-
-
Cabral, G.A.1
Griffin-Thomas, L.2
-
89
-
-
58049170379
-
Endocannabinoid signalling in microglial cells
-
Stella, N. Endocannabinoid signalling in microglial cells. Neuropharmacology, 2009, 56, 244-253
-
(2009)
Neuropharmacology
, vol.56
, pp. 244-253
-
-
Stella, N.1
-
90
-
-
38349087528
-
Cannabinoid CB2 receptors in human brain inflammation
-
Benito, C.; Tolón, R.M.; Pazos, M.R.; Núñez, E.; Castillo, A.I.; Romero, J. Cannabinoid CB2 receptors in human brain inflammation. Br. J. Pharmacol., 2008, 153(2), 277-285
-
(2008)
Br. J. Pharmacol.
, vol.153
, Issue.2
, pp. 277-285
-
-
Benito, C.1
Tolón, R.M.2
Pazos, M.R.3
Núñez, E.4
Castillo, A.I.5
Romero, J.6
-
91
-
-
29244478635
-
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
-
Ehrhart, J.; Obregon, D.; Mori, T.; Hou, H.; Sun, N.; Bai, Y.; Klein, T.; Fernandez, F.; Tan, J.; Shytle, R.D. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J. Neuroinflammation, 2005, 2, 29
-
(2005)
J. Neuroinflammation
, vol.2
, pp. 29
-
-
Ehrhart, J.1
Obregon, D.2
Mori, T.3
Hou, H.4
Sun, N.5
Bai, Y.6
Klein, T.7
Fernandez, F.8
Tan, J.9
Shytle, R.D.10
-
92
-
-
0030740514
-
The perceived effects of smoked cannabis on patients with multiple sclerosis
-
Consroe, P.; Musty, R.; Rein, J.; Tillery, W.; Pertwee, R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur. Neurol., 1997, 38(1), 44-48
-
(1997)
Eur. Neurol.
, vol.38
, Issue.1
, pp. 44-48
-
-
Consroe, P.1
Musty, R.2
Rein, J.3
Tillery, W.4
Pertwee, R.5
-
93
-
-
0036669791
-
Cannabinoids and multiple sclerosis
-
Pertwee, R.G. Cannabinoids and multiple sclerosis. Pharmacol. Ther., 2002, 95(2), 165-174
-
(2002)
Pharmacol. Ther.
, vol.95
, Issue.2
, pp. 165-174
-
-
Pertwee, R.G.1
-
94
-
-
0242654882
-
UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial
-
Zajicek, J.; Fox, P.; Sanders, H.; Wright, D.; Vickery, J.; Nunn, A.; Thompson, A.; UK MS Research Group. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet, 2003, 362(9395), 1517-1526
-
(2003)
Lancet
, vol.362
, Issue.9395
, pp. 1517-1526
-
-
Zajicek, J.1
Fox, P.2
Sanders, H.3
Wright, D.4
Vickery, J.5
Nunn, A.6
Thompson, A.7
-
95
-
-
28144454955
-
Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow up
-
Zajicek, J.P.; Sanders, H.P.; Wright, D.E.; Vickery, P.J.; Ingram, W.M.; Reilly, S.M.; Nunn, A.J.; Teare, L.J.; Fox, P.J.; Thompson, A.J. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J. Neurol. Neurosurg. Psychiatry., 2005, 76(12), 1664-1669
-
(2005)
J. Neurol. Neurosurg. Psychiatry.
, vol.76
, Issue.12
, pp. 1664-1669
-
-
Zajicek, J.P.1
Sanders, H.P.2
Wright, D.E.3
Vickery, P.J.4
Ingram, W.M.5
Reilly, S.M.6
Nunn, A.J.7
Teare, L.J.8
Fox, P.J.9
Thompson, A.J.10
-
96
-
-
0024596492
-
Delta 9-tetrahydrocannabinol: A novel treatment for experimental autoimmune encephalomyelitis
-
Lyman, W.D.; Sonett, J.R.; Brosnan, C.F.; Elkin, R.; Bornstein, M.B. Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J. Neuroimmunol., 1989, 23(1), 73-81
-
(1989)
J. Neuroimmunol.
, vol.23
, Issue.1
, pp. 73-81
-
-
Lyman, W.D.1
Sonett, J.R.2
Brosnan, C.F.3
Elkin, R.4
Bornstein, M.B.5
-
97
-
-
0028080884
-
Suppression of experimental autoimmune encephalomyelitis by cannabinoids
-
Wirguin, I.; Mechoulam, R.; Breuer, A.; Schezen, E.; Weidenfeld, J.; Brenner, T. Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology, 1994, 28(3), 209-214
-
(1994)
Immunopharmacology
, vol.28
, Issue.3
, pp. 209-214
-
-
Wirguin, I.1
Mechoulam, R.2
Breuer, A.3
Schezen, E.4
Weidenfeld, J.5
Brenner, T.6
-
98
-
-
0034594905
-
Cannabinoids control spasticity and tremor in a multiple sclerosis model
-
Baker, D.; Pryce, G.; Croxford, J.L.; Brown, P.; Pertwee, R.G.; Huffman, J.W.; Layward, L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature, 2000, 404(6773), 84-87
-
(2000)
Nature
, vol.404
, Issue.6773
, pp. 84-87
-
-
Baker, D.1
Pryce, G.2
Croxford, J.L.3
Brown, P.4
Pertwee, R.G.5
Huffman, J.W.6
Layward, L.7
-
99
-
-
34147165471
-
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
-
Maresz, K.; Pryce, G.; Ponomarev, E.D.; Marsicano, G.; Croxford, J.L.; Shriver, L.P.; Ledent, C.; Cheng, X.; Carrier, E.J.; Mann, M.K.; Giovannoni, G.; Pertwee, R.G.; Yamamura, T.; Buckley, N.E.; Hillard, C.J.; Lutz, B.; Baker, D.; Dittel, B.N. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med., 2007, 13(4), 492-497
-
(2007)
Nat. Med.
, vol.13
, Issue.4
, pp. 492-497
-
-
Maresz, K.1
Pryce, G.2
Ponomarev, E.D.3
Marsicano, G.4
Croxford, J.L.5
Shriver, L.P.6
Ledent, C.7
Cheng, X.8
Carrier, E.J.9
Mann, M.K.10
Giovannoni, G.11
Pertwee, R.G.12
Yamamura, T.13
Buckley, N.E.14
Hillard, C.J.15
Lutz, B.16
Baker, D.17
Dittel, B.N.18
-
101
-
-
3943102116
-
Unraveling the mechanisms involved in motor neuron degeneration in ALS
-
Bruijn, L.I.; Miller, T.M.; Cleveland, D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci., 2004, 27, 723-749
-
(2004)
Annu. Rev. Neurosci.
, vol.27
, pp. 723-749
-
-
Bruijn, L.I.1
Miller, T.M.2
Cleveland, D.W.3
-
102
-
-
16344364681
-
Advances in clinical trials for amyotrophic lateral sclerosis
-
Gordon, P.H. Advances in clinical trials for amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep., 2005, 5, 48-54
-
(2005)
Curr. Neurol. Neurosci. Rep.
, vol.5
, pp. 48-54
-
-
Gordon, P.H.1
-
103
-
-
0037393176
-
An outcome study of riluzole in amyotrophic lateral sclerosis - A population-based study in Ireland, 1996-2000
-
Traynor, B.J.; Alexander, M.; Corr, B.; Frost, E.; Hardiman, O. An outcome study of riluzole in amyotrophic lateral sclerosis-a population-based study in Ireland, 1996-2000. J. Neurol., 2003, 250, 473-479
-
(2003)
J. Neurol.
, vol.250
, pp. 473-479
-
-
Traynor, B.J.1
Alexander, M.2
Corr, B.3
Frost, E.4
Hardiman, O.5
-
104
-
-
0036787810
-
Inflammatory processes in amyotrophic lateral sclerosis
-
McGeer, P.L.; McGeer, E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve, 2002, 26, 459-470
-
(2002)
Muscle Nerve
, vol.26
, pp. 459-470
-
-
McGeer, P.L.1
McGeer, E.G.2
-
105
-
-
17844395669
-
Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis
-
Weydt, P.; Moller, T. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport, 2005, 16, 527-531
-
(2005)
Neuroreport
, vol.16
, pp. 527-531
-
-
Weydt, P.1
Moller, T.2
-
106
-
-
0036953725
-
Microglia in diseases of the central nervous system
-
Nelson, P.T.; Soma, L.A.; Lavi, E. Microglia in diseases of the central nervous system. Ann. Med., 2002, 34, 491-500
-
(2002)
Ann. Med.
, vol.34
, pp. 491-500
-
-
Nelson, P.T.1
Soma, L.A.2
Lavi, E.3
-
107
-
-
0029792449
-
Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: Pathological and immunocytochemical changes
-
Ince, P.G.; Shaw, P.J.; Slade, J.Y.; Jones, C.; Hudgson, P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. (Berl), 1996, 92, 395-403
-
(1996)
Acta Neuropathol. (Berl)
, vol.92
, pp. 395-403
-
-
Ince, P.G.1
Shaw, P.J.2
Slade, J.Y.3
Jones, C.4
Hudgson, P.5
-
108
-
-
1842471942
-
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study
-
Turner, M.R.; Cagnin, A.; Turkheimer, F.E.; Miller, C.C.; Shaw, C.E.; Brooks, D.J.; Leigh, P.N.; Banati, R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis., 2004, 15, 601-609
-
(2004)
Neurobiol. Dis.
, vol.15
, pp. 601-609
-
-
Turner, M.R.1
Cagnin, A.2
Turkheimer, F.E.3
Miller, C.C.4
Shaw, C.E.5
Brooks, D.J.6
Leigh, P.N.7
Banati, R.B.8
-
109
-
-
33645224970
-
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord
-
Yiangou, Y.; Facer, P.; Durrenberger, P.; Chessell, I.P.; Naylor, A.; Bountra, C.; Banati, R.R.; Anand, P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 2006, 6, 12
-
(2006)
BMC Neurol.
, vol.6
, pp. 12
-
-
Yiangou, Y.1
Facer, P.2
Durrenberger, P.3
Chessell, I.P.4
Naylor, A.5
Bountra, C.6
Banati, R.R.7
Anand, P.8
-
110
-
-
0030927253
-
Transgenic animal models of familial amyotrophic lateral sclerosis
-
Gurney, M.E. Transgenic animal models of familial amyotrophic lateral sclerosis. J. Neurol., 1997, 244(Suppl 2), 15-20
-
(1997)
J. Neurol.
, vol.244
, Issue.SUPPL. 2
, pp. 15-20
-
-
Gurney, M.E.1
-
111
-
-
33845683331
-
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice
-
Bilsland, L.G.; Dick, J.R.; Pryce, G.; Petrosino, S.; Di Marzo, V.; Baker, D.; Greensmith, L. Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. F A S E B J., 2006, 20, 1003-1005
-
(2006)
F A S e B J.
, vol.20
, pp. 1003-1005
-
-
Bilsland, L.G.1
Dick, J.R.2
Pryce, G.3
Petrosino, S.4
Di Marzo, V.5
Baker, D.6
Greensmith, L.7
-
112
-
-
2442484678
-
Amyotrophic lateral sclerosis: Delayed disease progression in mice by treatment with a cannabinoid
-
Raman, C.; McAllister, S.D.; Rizvi, G.; Patel, S.G.; Moore, D.H.; Abood, M.E. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph. Lateral Scler. Other Motor Neuron. Disord., 2004, 5, 33-39
-
(2004)
Amyotroph. Lateral Scler. Other Motor Neuron. Disord.
, vol.5
, pp. 33-39
-
-
Raman, C.1
McAllister, S.D.2
Rizvi, G.3
Patel, S.G.4
Moore, D.H.5
Abood, M.E.6
-
113
-
-
26444608731
-
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival
-
Weydt, P.; Hong, S.; Witting, A.; Moller, T.; Stella, N.; Kliot, M. Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotroph. Lateral Scler. Other Motor Neuron. Disord., 2005, 6, 182-184
-
(2005)
Amyotroph. Lateral Scler. Other Motor Neuron. Disord.
, vol.6
, pp. 182-184
-
-
Weydt, P.1
Hong, S.2
Witting, A.3
Moller, T.4
Stella, N.5
Kliot, M.6
-
114
-
-
77955981912
-
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS
-
Gorantla, S.; Makarov, E.; Roy, D.; Finke-Dwyer, J.; Murrin, L.C.; Gendelman, H.E.; Poluektova, L. Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS. Neuroimmune Pharmacol., 2010, 5(3), 456-468
-
(2010)
Neuroimmune Pharmacol.
, vol.5
, Issue.3
, pp. 456-468
-
-
Gorantla, S.1
Makarov, E.2
Roy, D.3
Finke-Dwyer, J.4
Murrin, L.C.5
Gendelman, H.E.6
Poluektova, L.7
-
115
-
-
0037043658
-
Inflammatory bowel disease
-
Podolsky, D.K. Inflammatory bowel disease. N. Engl. J. Med., 2002, 347(6), 417-429
-
(2002)
N. Engl. J. Med.
, vol.347
, Issue.6
, pp. 417-429
-
-
Podolsky, D.K.1
-
116
-
-
23244457833
-
Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing
-
Wright, K.; Rooney, N.; Feeney, M.; Tate, J.; Robertson, D.; Welham, M.; Ward, S. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005, 129(2), 437-453
-
(2005)
Gastroenterology
, vol.129
, Issue.2
, pp. 437-453
-
-
Wright, K.1
Rooney, N.2
Feeney, M.3
Tate, J.4
Robertson, D.5
Welham, M.6
Ward, S.7
-
117
-
-
0037219120
-
Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids
-
Ihenetu, K.; Molleman, A.; Parsons, M.E.; Whelan, C.J. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Eur. J. Pharmacol., 2003, 458(1-2), 207-215
-
(2003)
Eur. J. Pharmacol.
, vol.458
, Issue.1-2
, pp. 207-215
-
-
Ihenetu, K.1
Molleman, A.2
Parsons, M.E.3
Whelan, C.J.4
-
118
-
-
23344449020
-
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota
-
Elson, C.O.; Cong, Y.; McCracken, V.J.; Dimmitt, R.A.; Lorenz, R.G.; Weaver, C.T. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev., 2005, 206, 260-276
-
(2005)
Immunol. Rev.
, vol.206
, pp. 260-276
-
-
Elson, C.O.1
Cong, Y.2
McCracken, V.J.3
Dimmitt, R.A.4
Lorenz, R.G.5
Weaver, C.T.6
-
119
-
-
11144355734
-
The endogenous cannabinoid system protects against colonic inflammation
-
Massa, F.; Marsicano, G.; Hermann, H.; Cannich, A.; Monory, K.; Cravatt, B.F.; Ferri, G.L.; Sibaev, A.; Storr, M.; Lutz, B. The endogenous cannabinoid system protects against colonic inflammation. J. Clin. Invest., 2004, 113, 1202-1209
-
(2004)
J. Clin. Invest.
, vol.113
, pp. 1202-1209
-
-
Massa, F.1
Marsicano, G.2
Hermann, H.3
Cannich, A.4
Monory, K.5
Cravatt, B.F.6
Ferri, G.L.7
Sibaev, A.8
Storr, M.9
Lutz, B.10
-
120
-
-
33745783119
-
Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium
-
Kimball, E.S.; Schneider, C.R.; Wallace, N.H.; Hornby, P.J. Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 291(2), G364-G371
-
(2006)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.291
, Issue.2
-
-
Kimball, E.S.1
Schneider, C.R.2
Wallace, N.H.3
Hornby, P.J.4
-
121
-
-
38349126757
-
Cannabinoid receptor 2 is required for homeostasis control of intestinal inflammation
-
Thuru, X.; Chamaillard, M.; Karsak, M.; Gantier, E.; Erdual, E.; Dubuquoy, C.; Phillipe, D.; Rousseaux, C.; Wang, Y.C.; Dubus, P.; Stalewski, J.; Menzaghi, F.; Schteingart, C.; Zimmer, A.; Riviere, P.; Desreumaux, P. Cannabinoid receptor 2 is required for homeostasis control of intestinal inflammation. Gastroenterology, 2007, 132(Suppl 2), A228
-
(2007)
Gastroenterology
, vol.132
, Issue.SUPPL. 2
-
-
Thuru, X.1
Chamaillard, M.2
Karsak, M.3
Gantier, E.4
Erdual, E.5
Dubuquoy, C.6
Phillipe, D.7
Rousseaux, C.8
Wang, Y.C.9
Dubus, P.10
Stalewski, J.11
Menzaghi, F.12
Schteingart, C.13
Zimmer, A.14
Riviere, P.15
Desreumaux, P.16
-
122
-
-
72549108949
-
Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
-
Storr, M.A.; Keenan, C.M.; Zhang, H.; Patel, K.D.; Makriyannis, A.; Sharkey, K.A. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm. Bowel Dis., 2009, 15(11), 1678-1685
-
(2009)
Inflamm. Bowel Dis.
, vol.15
, Issue.11
, pp. 1678-1685
-
-
Storr, M.A.1
Keenan, C.M.2
Zhang, H.3
Patel, K.D.4
Makriyannis, A.5
Sharkey, K.A.6
-
123
-
-
38349106773
-
AM1241, a CB2-specific agonist protects against immune but not acute colitis
-
Ziring, D.A.; Braun, J. AM1241, a CB2-specific agonist protects against immune but not acute colitis. Gastroenterology, 2007, 132(Suppl 2), A232
-
(2007)
Gastroenterology
, vol.132
, Issue.SUPPL. 2
-
-
Ziring, D.A.1
Braun, J.2
-
124
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
Hansson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352(16), 1685-1695
-
(2005)
N. Engl. J. Med.
, vol.352
, Issue.16
, pp. 1685-1695
-
-
Hansson, G.K.1
-
125
-
-
0034648768
-
Atherosclerosis
-
Lusis, A.J. Atherosclerosis. Nature, 2000, 407, 233-241
-
(2000)
Nature
, vol.407
, pp. 233-241
-
-
Lusis, A.J.1
-
126
-
-
17144400758
-
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
-
Steffens, S.; Veillard, N.R.; Arnaud, C.; Pelli, G.; Burger, F.; Staub, C.; Karsak, M.; Zimmer, A.; Frossard, J.L.; Mach, F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature, 2005, 434(7034), 782-786
-
(2005)
Nature
, vol.434
, Issue.7034
, pp. 782-786
-
-
Steffens, S.1
Veillard, N.R.2
Arnaud, C.3
Pelli, G.4
Burger, F.5
Staub, C.6
Karsak, M.7
Zimmer, A.8
Frossard, J.L.9
MacH, F.10
-
127
-
-
0034662868
-
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
-
Malfait, A.M.; Gallily, R.; Sumariwalla, P.F.; Malik, A.S.; Andreakos, E.; Mechoulam, R.; Feldmann, M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA, 2000, 97(17), 9561-9566
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, Issue.17
, pp. 9561-9566
-
-
Malfait, A.M.1
Gallily, R.2
Sumariwalla, P.F.3
Malik, A.S.4
Andreakos, E.5
Mechoulam, R.6
Feldmann, M.7
-
128
-
-
33751100172
-
R-(+)-[2, 3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1, 2, 3-de]-1, 4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB(2) receptor
-
Sanchez, A.J.; Gonzalez-Perez, P.; Galve-Roperh, I.; Garcia-Merino, A. R-(+)-[2, 3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1, 2, 3-de]-1, 4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor. Biochem. Pharmacol., 2006, 72(12), 1697-1706
-
(2006)
Biochem. Pharmacol.
, vol.72
, Issue.12
, pp. 1697-1706
-
-
Sanchez, A.J.1
Gonzalez-Perez, P.2
Galve-Roperh, I.3
Garcia-Merino, A.4
-
129
-
-
17144462251
-
Therapeutic action of cannabinoids in a murine model of multiple sclerosis
-
Arevalo-Martin, A.; Vela, J.M.; Molina-Holgado, E.; Borrell, J.; Guaza, C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci., 2003, 23(7), 2511-2516
-
(2003)
J. Neurosci.
, vol.23
, Issue.7
, pp. 2511-2516
-
-
Arevalo-Martin, A.1
Vela, J.M.2
Molina-Holgado, E.3
Borrell, J.4
Guaza, C.5
-
130
-
-
80055107075
-
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo
-
Hoyer, F.F.; Steinmetz, M.; Zimmer, S.; Becker, A.; Lütjohann, D.; Buchalla, R.; Zimmer, A.; Nickenig, G. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. J. Mol. Cell. Cardiol., 2011, 51(6), 1007-1014
-
(2011)
J. Mol. Cell. Cardiol.
, vol.51
, Issue.6
, pp. 1007-1014
-
-
Hoyer, F.F.1
Steinmetz, M.2
Zimmer, S.3
Becker, A.4
Lütjohann, D.5
Buchalla, R.6
Zimmer, A.7
Nickenig, G.8
-
132
-
-
12344253624
-
Rheumatoid arthritis, inflammation, and atherosclerosis
-
Hurlimann, D.; Enseleit, F.; Ruschitzka, F. Rheumatoid arthritis, inflammation, and atherosclerosis. Herz, 2004, 29, 760-768
-
(2004)
Herz
, vol.29
, pp. 760-768
-
-
Hurlimann, D.1
Enseleit, F.2
Ruschitzka, F.3
-
133
-
-
0029876121
-
Role of cytokines in rheumatoid arthritis
-
Feldmann, M.; Brennan, F.M.; Maini, R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol., 1996, 14, 397-440
-
(1996)
Annu. Rev. Immunol.
, vol.14
, pp. 397-440
-
-
Feldmann, M.1
Brennan, F.M.2
Maini, R.N.3
-
134
-
-
23044486763
-
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
-
Croxford, J.L.; Yamamura, T. Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? J. Neuroimmunol., 2005, 166, 3-18
-
(2005)
J. Neuroimmunol.
, vol.166
, pp. 3-18
-
-
Croxford, J.L.1
Yamamura, T.2
-
135
-
-
31444437185
-
Peripheral cannabinoid receptor, CB2, regulates bone mass
-
Ofek, O.; Karsak, M.; Leclerc, N.; Fogel, M.; Frenkel, B.; Wright, K.; Tam, J.; Attar-Namdar, M.; Kram, V.; Shohami, E.; Mechoulam, R.; Zimmer, A.; Bab, I. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl. Acad. Sci. USA, 2006, 103, 696-701
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 696-701
-
-
Ofek, O.1
Karsak, M.2
Leclerc, N.3
Fogel, M.4
Frenkel, B.5
Wright, K.6
Tam, J.7
Attar-Namdar, M.8
Kram, V.9
Shohami, E.10
Mechoulam, R.11
Zimmer, A.12
Bab, I.13
-
136
-
-
41849090731
-
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid
-
Parker, J.; Atez, F.; Rossetti, R.G.; Skulas, A.; Patel, R.; Zurier, R.B. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. Rheumatol Int., 2008, 28, 631-635
-
(2008)
Rheumatol Int.
, vol.28
, pp. 631-635
-
-
Parker, J.1
Atez, F.2
Rossetti, R.G.3
Skulas, A.4
Patel, R.5
Zurier, R.B.6
-
137
-
-
0037441413
-
Suppression of human monocyte interleukin-1 ßproduction by ajulemic acid, a nonpsycho active cannabinoid
-
Zurier, R.B.; Rossetti, R.G.; Burstein, S.H.; Bidinger, B. Suppression of human monocyte interleukin-1 ßproduction by ajulemic acid, a nonpsycho active cannabinoid. Biochem. Pharmacol, 2003, 65, 649-655
-
(2003)
Biochem. Pharmacol
, vol.65
, pp. 649-655
-
-
Zurier, R.B.1
Rossetti, R.G.2
Burstein, S.H.3
Bidinger, B.4
-
138
-
-
38449111261
-
Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells
-
George, K.L.; Saltman, L.H.; Stein, G.S.; Lian, J.B.; Zurier, R.B. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells. J. Cell. Physiol, 2008, 214, 714-720
-
(2008)
J. Cell. Physiol
, vol.214
, pp. 714-720
-
-
George, K.L.1
Saltman, L.H.2
Stein, G.S.3
Lian, J.B.4
Zurier, R.B.5
-
139
-
-
0035901090
-
Inflammation and cancer: Back to Virchow?
-
Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357, 539-545
-
(2001)
Lancet
, vol.357
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
140
-
-
0032881237
-
Therapeutic approaches for ischemia/reperfusion injury in the liver
-
Fan, C.; Zwacka, R.M.; Engelhardt, J.F Therapeutic approaches for ischemia/reperfusion injury in the liver. J. Mol Med., 1999, 77, 577-592
-
(1999)
J. Mol Med.
, vol.77
, pp. 577-592
-
-
Fan, C.1
Zwacka, R.M.2
Engelhardt, J.F.3
-
141
-
-
0141594593
-
Apoptosis versus oncotic necrosis in hepatic ischemia/rep erfusion injury
-
Jaeschke, H.; Lemasters, J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/rep erfusion injury. Gastroenterology, 2003, 125, 1246-1257
-
(2003)
Gastroenterology
, vol.125
, pp. 1246-1257
-
-
Jaeschke, H.1
Lemasters, J.J.2
-
142
-
-
20344379953
-
Ischemia and reperfusion injury in liver transplantation
-
Kupiec-Weglinski, J.W.; Busuttil, R.W. Ischemia and reperfusion injury in liver transplantation. Transpl. Proc, 2005, 37, 1653-1656
-
(2005)
Transpl. Proc
, vol.37
, pp. 1653-1656
-
-
Kupiec-Weglinski, J.W.1
Busuttil, R.W.2
-
143
-
-
18144401711
-
Anti-inflammatory approaches to the prevention of ischemia/rep erfusion injury in solid organ transplantation
-
Husted, T.L.; Lentsch, A.B. Anti-inflammatory approaches to the prevention of ischemia/rep erfusion injury in solid organ transplantation. Curr. Opin. Investig. Drugs, 2005, 6, 508-512
-
(2005)
Curr. Opin. Investig. Drugs
, vol.6
, pp. 508-512
-
-
Husted, T.L.1
Lentsch, A.B.2
-
144
-
-
21644433002
-
Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury
-
Szabo, G.; Bahrle, S. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury. Curr. Vasc. Pharmacol, 2005, 3, 215-220
-
(2005)
Curr. Vasc. Pharmacol
, vol.3
, pp. 215-220
-
-
Szabo, G.1
Bahrle, S.2
-
145
-
-
33644631485
-
Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol
-
Pacher, P.; Nivorozhkin, A.; Szabo, C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., 2006, 58, 87-114
-
(2006)
Pharmacol. Rev.
, vol.58
, pp. 87-114
-
-
Pacher, P.1
Nivorozhkin, A.2
Szabo, C.3
-
146
-
-
33748703859
-
The endocannabinoid system as an emerging target of pharmacotherapy
-
Pacher, P.; Bátkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58, 389-462
-
(2006)
Pharmacol. Rev.
, vol.58
, pp. 389-462
-
-
Pacher, P.1
Bátkai, S.2
Kunos, G.3
-
148
-
-
19444369394
-
Blood pressure regulation by endocannabinoids and their receptors
-
Pacher, P.; Bátkai, S.; Kunos, G. Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology, 2005, 48, 1130-1138
-
(2005)
Neuropharmacology
, vol.48
, pp. 1130-1138
-
-
Pacher, P.1
Bátkai, S.2
Kunos, G.3
-
150
-
-
34249788152
-
Cannabinoid-2 receptor mediates protection against hepatic ischemia/rep erfusion injury
-
Bátkai, S.; Osei-Hy iaman, D.; Pan, H.; El-Assal, O.; Rajesh, M.; Mukhopadhyay, P.; Hong, F.; Harvey-White, J.; Jafri, A.; Haskó, G.; Huffman, J.W.; Gao, B.; Kunos, G.; Pacher, P. Cannabinoid-2 receptor mediates protection against hepatic ischemia/rep erfusion injury. FASEB J., 2007, 21(8), 1788-1800
-
(2007)
FASEB J.
, vol.21
, Issue.8
, pp. 1788-1800
-
-
Bátkai, S.1
Osei-Hy Iaman, D.2
Pan, H.3
El-Assal, O.4
Rajesh, M.5
Mukhopadhyay, P.6
Hong, F.7
Harvey-White, J.8
Jafri, A.9
Haskó, G.10
Huffman, J.W.11
Gao, B.12
Kunos, G.13
Pacher, P.14
-
151
-
-
14644433021
-
Medical use of cannabis in the Netherlands
-
Gorter, R.W.; Butorac, M.; Pulido Cobian, E.; van der Sluis, W. Medical use of cannabis in the Netherlands. Neurology, 2005, 64, 917-919
-
(2005)
Neurology
, vol.64
, pp. 917-919
-
-
Gorter, R.W.1
Butorac, M.2
Pulido Cobian, E.3
Van Der Sluis, W.4
-
152
-
-
78249232046
-
Review on clinical studies with cannabis and cannabinoids 2005-2009
-
special issue
-
Hazekamp, A.; Grotenhermen, F. Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids, 2010, 5(special issue), 1-21
-
(2010)
Cannabinoids
, vol.5
, pp. 1-21
-
-
Hazekamp, A.1
Grotenhermen, F.2
-
153
-
-
34250202493
-
Discovery of 2-[2, 4-dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl) methyl]-4-(trifluoromethyl)-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain
-
Giblin, G.M.; O'Shaughnessy, C.T.; Naylor, A.; Mitchell, W.L.; Eatherton, A.J.; Slingsby, B.P; Rawlings, D.A.; Goldsmith, P.; Brown, A.J.; Haslam, C.P; Clayton, N.M.; Wilson, A.W.; Chessell, I.P; Wittington, A.R.; Green, R. Discovery of 2-[(2, 4-dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl] -4-(trifluoromethyl)-5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain. J. Med. Chem., 2007, 50(11), 2597-600
-
(2007)
J. Med. Chem.
, vol.50
, Issue.11
, pp. 2597-2600
-
-
Giblin, G.M.1
O'Shaughnessy, C.T.2
Naylor, A.3
Mitchell, W.L.4
Eatherton, A.J.5
Slingsby, B.P.6
Rawlings, D.A.7
Goldsmith, P.8
Brown, A.J.9
Haslam, C.P.10
Clayton, N.M.11
Wilson, A.W.12
Chessell, I.P.13
Wittington, A.R.14
Green, R.15
-
154
-
-
84880856297
-
-
PBRHome Accessed Apr 19, 2012
-
PBRHome. Glenmark completes Phase I inflammatory pain trial. http://drugdiscovery.pharmaceutical-business-review.com/news/ glenmark-completes-phase-i-inflammatory-pain-trial-14 0409 (Accessed Apr 19, 2012)
-
Glenmark Completes Phase i Inflammatory Pain Trial
-
-
-
157
-
-
0023791260
-
Enantiomeric cannabinoids: Stereo specificity of psychotropic activity
-
Mechoulam, R.; Feigenbaum, J.J.; Lander, N; Segal, M.; Järbe, T.U.; Hiltunen, A.J.; Consroe, P. Enantiomeric cannabinoids: stereo specificity of psychotropic activity. Experientia, 1988, 44(9), 762-764
-
(1988)
Experientia
, vol.44
, Issue.9
, pp. 762-764
-
-
Mechoulam, R.1
Feigenbaum, J.J.2
Lander, N.3
Segal, M.4
Järbe, T.U.5
Hiltunen, A.J.6
Consroe, P.7
-
158
-
-
0029846519
-
Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor
-
Huffman, J.W.; Yu, S.; Showalter, V.; Abood, M.E.; Wiley, J.L.; Compton, D.R.; Martin, B.R.; Bramblett, R.D.; Reggio, PH. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor. J. Med. Chem., 1996, 39(20), 3875-3877
-
(1996)
J. Med. Chem.
, vol.39
, Issue.20
, pp. 3875-3877
-
-
Huffman, J.W.1
Yu, S.2
Showalter, V.3
Abood, M.E.4
Wiley, J.L.5
Compton, D.R.6
Martin, B.R.7
Bramblett, R.D.8
Reggio, P.H.9
-
159
-
-
0033381793
-
3-(1', 1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: Synthesis of selective ligands for the CB2 receptor
-
Huffman, J.W.; Liddle, J.; Yu, S.; Aung, M.; Abood, M.E.; Wiley, J.L.; Martin, B.R. 3-(1', 1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem., 1999, 7(12), 2905-2914
-
(1999)
Bioorg. Med. Chem.
, vol.7
, Issue.12
, pp. 2905-2914
-
-
Huffman, J.W.1
Liddle, J.2
Yu, S.3
Aung, M.4
Abood, M.E.5
Wiley, J.L.6
Martin, B.R.7
-
160
-
-
28944438774
-
The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro
-
Jonsson, K.O.; Persson, E.; Fowler, C.J. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro. Life Sci., 2006, 78(6), 598-606
-
(2006)
Life Sci.
, vol.78
, Issue.6
, pp. 598-606
-
-
Jonsson, K.O.1
Persson, E.2
Fowler, C.J.3
-
161
-
-
0346993609
-
A novel methodology for the synthesis of 1-desoxy-Delta(8)-
-
Sun, H.; Mahadevan, A.; Razdan, R.K. A novel methodology for the synthesis of 1-desoxy-Delta(8)-tetrahydrocannabinol (THC) analogues. Tet. Lett, 2004, 45, 615-617
-
(2004)
Tet. Lett
, vol.45
, pp. 615-617
-
-
Sun, H.1
Mahadevan, A.2
Razdan, R.K.3
-
162
-
-
78650807828
-
The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
-
Kinsey, S.G.; Mahadevan, A.; Zhao, B.; Sun, H.; Naidu, P.S.; Razdan, R.K.; Selley, D.E.; Imad Damaj, M.; Lichtman, A.H. The CB(2) cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects. Neuropharmacology, 2011, 60(2-3), 244-251
-
(2011)
Neuropharmacology
, vol.60
, Issue.2-3
, pp. 244-251
-
-
Kinsey, S.G.1
Mahadevan, A.2
Zhao, B.3
Sun, H.4
Naidu, P.S.5
Razdan, R.K.6
Selley, D.E.7
Imad Damaj, M.8
Lichtman, A.H.9
-
163
-
-
0001850107
-
Structural requirements for cannabinoid activity
-
Edery, H.; Grunfeld, Y.; Ben-Zvi, Z.; Mechoulam, R. Structural requirements for cannabinoid activity. Ann. N.Y. Acad. Sci., 1971, 191, 40-53
-
(1971)
Ann. N.Y. Acad. Sci.
, vol.191
, pp. 40-53
-
-
Edery, H.1
Grunfeld, Y.2
Ben-Zvi, Z.3
Mechoulam, R.4
-
164
-
-
0030046270
-
Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
-
Gareau, Y.; Dufresne, C.; Gallant, M.; Richette, C.; Sawyer, N.; Slipetz, D.M.; Tremblay, N.; Weech, P.K.; Metters, K.M.; Labelloe, M. Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors. Bioorg. Med. Chem. Lett., 1996, 6, 189-194
-
(1996)
Bioorg. Med. Chem. Lett.
, vol.6
, pp. 189-194
-
-
Gareau, Y.1
Dufresne, C.2
Gallant, M.3
Richette, C.4
Sawyer, N.5
Slipetz, D.M.6
Tremblay, N.7
Weech, P.K.8
Metters, K.M.9
Labelloe, M.10
-
165
-
-
12944263838
-
HU-308: A specific agonist for CB(2), a peripheral cannabinoid receptor
-
Hanus, L.; Breuer, A.; Tchilibon, S.; Shiloah, S.; Goldenberg, D.; Horowitz, M.; Pertwee, R.G.; Ross, R.A.; Mechoulam, R.; Fride, E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. USA, 1999, 96(25), 14228-14233
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, Issue.25
, pp. 14228-14233
-
-
Hanus, L.1
Breuer, A.2
Tchilibon, S.3
Shiloah, S.4
Goldenberg, D.5
Horowitz, M.6
Pertwee, R.G.7
Ross, R.A.8
Mechoulam, R.9
Fride, E.10
-
166
-
-
37249091964
-
Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
-
Rajesh, M.; Pan, H.; Mukhopadhyay, P.; Bátkai, S.; Osei-Hyiaman, D.; Haskó, G.; Liaudet, L.; Gao, B.; Pacher, P. Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J. Leukoc. Biol., 2007, 82, 1382-1389
-
(2007)
J. Leukoc. Biol.
, vol.82
, pp. 1382-1389
-
-
Rajesh, M.1
Pan, H.2
Mukhopadhyay, P.3
Bátkai, S.4
Osei-Hyiaman, D.5
Haskó, G.6
Liaudet, L.7
Gao, B.8
Pacher, P.9
-
167
-
-
21644464904
-
CB2 receptor ligands
-
Huffman, J.W. CB2 receptor ligands. Mini Rev. Med. Chem., 2005, 5(7), 641-649
-
(2005)
Mini Rev. Med. Chem.
, vol.5
, Issue.7
, pp. 641-649
-
-
Huffman, J.W.1
-
168
-
-
84859029863
-
A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury
-
Horváth, B.; Magid, L.; Mukhopadhyay, P.; Bátkai, S.; Rajesh, M.; Park, O.; Tanchian, G.; Gao, R.Y.; Goodfellow, C.E.; Glass, M.; Mechoulam, R.; Pacher, P. A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury. B r. J. Pharmacol., 2012, 165, 2462-2478
-
(2012)
B R. J. Pharmacol.
, vol.165
, pp. 2462-2478
-
-
Horváth, B.1
Magid, L.2
Mukhopadhyay, P.3
Bátkai, S.4
Rajesh, M.5
Park, O.6
Tanchian, G.7
Gao, R.Y.8
Goodfellow, C.E.9
Glass, M.10
Mechoulam, R.11
Pacher, P.12
-
169
-
-
34548538407
-
Cannabinoids and the Endocannabinoid System
-
Grotenhermen, F. Cannabinoids and the Endocannabinoid System. Cannabinoids, 2006, 1(1), 10-14
-
(2006)
Cannabinoids
, vol.1
, Issue.1
, pp. 10-14
-
-
Grotenhermen, F.1
-
170
-
-
78651277573
-
Acute effects of a novel peripheral selective cannabinoid-2-receptor agonist (cannabinor) on bladder function in conscious rats
-
Gratzke, C.; Streng, T.; Stief, C.G.; Downs, T.R.; Alroy, I.; Rosenbaum, J.S.; Hedlund, P. Acute effects of a novel peripheral selective cannabinoid-2-receptor agonist (cannabinor) on bladder function in conscious rats. Eur. Urol. Suppl., 2010, 8, 271
-
(2010)
Eur. Urol. Suppl.
, vol.8
, pp. 271
-
-
Gratzke, C.1
Streng, T.2
Stief, C.G.3
Downs, T.R.4
Alroy, I.5
Rosenbaum, J.S.6
Hedlund, P.7
-
171
-
-
33845196807
-
-
Pharmos Accessed Oct 27, 2011
-
Pharmos. CB2-selective program: cannabinor. http://www.pharmoscorp.com/ development/cannabinor.html (Accessed Oct 27, 2011)
-
CB2-selective Program: Cannabinor
-
-
-
172
-
-
0025755870
-
Antiniociceptive (aminoalkyl)indoles
-
Bell, M.R.; Dambra, T.E.; Kumar, V.; Eissenstat, M.A.; Herrmann, J.L.; Wetzel, J.R.; Rosi, D.; Philion, R.E.; Daum, S.J.; Hlasta, D.J.; Kullnig, R.K.; Ackerman, J.H.; Haubrich, D.R.; Luttinger, D.A.; Baizman, E.R.; Miller, M.S.; Ward, S.J. Antiniociceptive (aminoalkyl)indoles. J. Med. Chem., 1991, 34, 1099-1110
-
(1991)
J. Med. Chem.
, vol.34
, pp. 1099-1110
-
-
Bell, M.R.1
Dambra, T.E.2
Kumar, V.3
Eissenstat, M.A.4
Herrmann, J.L.5
Wetzel, J.R.6
Rosi, D.7
Philion, R.E.8
Daum, S.J.9
Hlasta, D.J.10
Kullnig, R.K.11
Ackerman, J.H.12
Haubrich, D.R.13
Luttinger, D.A.14
Baizman, E.R.15
Miller, M.S.16
Ward, S.J.17
-
173
-
-
0026598734
-
Conformationally restrained analogues of pravadoline: Nanomolar potent enantioselective (aminoalkyl)indole agonists of the cannabinoid receptor
-
D'Ambra, T.E.; Estep, K.G.; Bell, M.R.; Eissenstat, M.A.; Josef, K.A.; Ward, S.J.; Haycock, D.A.; Baizman, E.R.; Casiano, F.M.; Beglin, N.C.; Chippari, S.M.; Grego, J.D.; Kullnig, R.K.; Daley, G.T. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem., 1992, 35(1), 124-135
-
(1992)
J. Med. Chem.
, vol.35
, Issue.1
, pp. 124-135
-
-
D'Ambra, T.E.1
Estep, K.G.2
Bell, M.R.3
Eissenstat, M.A.4
Josef, K.A.5
Ward, S.J.6
Haycock, D.A.7
Baizman, E.R.8
Casiano, F.M.9
Beglin, N.C.10
Chippari, S.M.11
Grego, J.D.12
Kullnig, R.K.13
Daley, G.T.14
-
174
-
-
0030425575
-
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
-
Showalter, V.M.; Compton, D.R.; Martin, B.R.; Abood, M.E. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 1996, 278(3), 989-999
-
(1996)
J. Pharmacol. Exp. Ther.
, vol.278
, Issue.3
, pp. 989-999
-
-
Showalter, V.M.1
Compton, D.R.2
Martin, B.R.3
Abood, M.E.4
-
175
-
-
0025787612
-
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
-
Martin, B.R.; Compton, D.R.; Thomas, B.F.; Prescott, W.R.; Little, P.J.; Razdan, R.K.; Johnson, M.R.; Melvin, L.S.; Mechoulam, R.; Ward, S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav., 1991, 40(3), 471-478
-
(1991)
Pharmacol. Biochem. Behav.
, vol.40
, Issue.3
, pp. 471-478
-
-
Martin, B.R.1
Compton, D.R.2
Thomas, B.F.3
Prescott, W.R.4
Little, P.J.5
Razdan, R.K.6
Johnson, M.R.7
Melvin, L.S.8
Mechoulam, R.9
Ward, S.J.10
-
176
-
-
0029134729
-
Aminoalkylindoles: Structure-activity relationships of novel cannabinoid mimetics
-
Eissenstat, M.A.; Bell, M.R.; D'Ambra, T.E.; Alexander, E.J.; Daum, S.J.; Ackerman, J.H.; Gruett, M.D.; Kumar, V.; Estep, K.G.; Olefirowicz, E.M.; Wetzel, J.R.; Alexander, M.D.; Weaver, J.D.; Haycock, D.A.; Luttinger, D.A.; Casiano, F.M.; Chippari, S.M.; Kuster, J.E.; Stevenson, J.I.; Ward, S.J. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. J. Med. Chem., 1995, 38(16), 3094-3105
-
(1995)
J. Med. Chem.
, vol.38
, Issue.16
, pp. 3094-3105
-
-
Eissenstat, M.A.1
Bell, M.R.2
D'Ambra, T.E.3
Alexander, E.J.4
Daum, S.J.5
Ackerman, J.H.6
Gruett, M.D.7
Kumar, V.8
Estep, K.G.9
Olefirowicz, E.M.10
Wetzel, J.R.11
Alexander, M.D.12
Weaver, J.D.13
Haycock, D.A.14
Luttinger, D.A.15
Casiano, F.M.16
Chippari, S.M.17
Kuster, J.E.18
Stevenson, J.I.19
Ward, S.J.20
more..
-
177
-
-
0025787612
-
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
-
Martin, B.R.; Compton, D.R.; Thomas, B.F.; Prescott, W.R.; Little, P.J.; Razdan, R.K.; Johnson, M.R.; Melvin, L.S.; Mechoulam, R.; Ward, S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav., 1991, 40(3), 471-478
-
(1991)
Pharmacol. Biochem. Behav.
, vol.40
, Issue.3
, pp. 471-478
-
-
Martin, B.R.1
Compton, D.R.2
Thomas, B.F.3
Prescott, W.R.4
Little, P.J.5
Razdan, R.K.6
Johnson, M.R.7
Melvin, L.S.8
Mechoulam, R.9
Ward, S.J.10
-
178
-
-
0026969158
-
Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol
-
Compton, D.R.; Gold, L.H.; Ward, S.J.; Balster, R.L.; Martin, B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 1992, 263(3), 1118-1126
-
(1992)
J. Pharmacol. Exp. Ther.
, vol.263
, Issue.3
, pp. 1118-1126
-
-
Compton, D.R.1
Gold, L.H.2
Ward, S.J.3
Balster, R.L.4
Martin, B.R.5
-
179
-
-
0035800564
-
Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands
-
Smith, S.R.; Terminelli, C.; Denhardt, G. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands. Eur. J. Pharmacol., 2001, 425(1), 73-83
-
(2001)
Eur. J. Pharmacol.
, vol.425
, Issue.1
, pp. 73-83
-
-
Smith, S.R.1
Terminelli, C.2
Denhardt, G.3
-
180
-
-
0034069673
-
Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice
-
Smith, S.R.; Terminelli, C.; Denhardt, G. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J. Pharmacol. Exp. Ther., 2000, 293(1), 136-150
-
(2000)
J. Pharmacol. Exp. Ther.
, vol.293
, Issue.1
, pp. 136-150
-
-
Smith, S.R.1
Terminelli, C.2
Denhardt, G.3
-
181
-
-
0036179292
-
Effect of the cannabinoid receptor ligand, WIN 55, 212-2, on superoxide anion and TNF-alpha production by human mononuclear cells
-
Germain, N.; Boichot, E.; Advenier, C.; Berdyshev, E.V.; Lagente, V. Effect of the cannabinoid receptor ligand, WIN 55, 212-2, on superoxide anion and TNF-alpha production by human mononuclear cells. Int. Immunopharmacol., 2002, 2(4), 537-543
-
(2002)
Int. Immunopharmacol.
, vol.2
, Issue.4
, pp. 537-543
-
-
Germain, N.1
Boichot, E.2
Advenier, C.3
Berdyshev, E.V.4
Lagente, V.5
-
182
-
-
33846335526
-
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation
-
Marchalant, Y.; Rosi, S.; Wenk, G.L. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience, 2007, 144(4), 1516-1522
-
(2007)
Neuroscience
, vol.144
, Issue.4
, pp. 1516-1522
-
-
Marchalant, Y.1
Rosi, S.2
Wenk, G.L.3
-
183
-
-
33646508077
-
Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2-arachidonoylglycerol
-
Oka, S.; Wakui, J.; Gokoh, M.; Kishimoto, S.; Sugiura, T. Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse ear: Interference with the actions of an endogenous ligand, 2- arachidonoylglycerol. Eur. J. Pharm., 2006, 538, 154-162
-
(2006)
Eur. J. Pharm.
, vol.538
, pp. 154-162
-
-
Oka, S.1
Wakui, J.2
Gokoh, M.3
Kishimoto, S.4
Sugiura, T.5
-
184
-
-
0024263922
-
Determination and characterization of a cannabinoid receptor in rat brain
-
Devane, K.A.; Dysan, F.A.III; Johnsson, M.R.; Melvin, L.S.; Howlett, A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 1988, 34(5), 605-613
-
(1988)
Mol. Pharmacol.
, vol.34
, Issue.5
, pp. 605-613
-
-
Devane, K.A.1
Dysan III, F.A.2
Johnsson, M.R.3
Melvin, L.S.4
Howlett, A.C.5
-
185
-
-
0027225185
-
Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach
-
Reggio, P.H.; Panu, A.M.; Miles, S. Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach. J. Med Chem., 1993, 36(12), 1761-1771
-
(1993)
J. Med Chem.
, vol.36
, Issue.12
, pp. 1761-1771
-
-
Reggio, P.H.1
Panu, A.M.2
Miles, S.3
-
186
-
-
0028323255
-
Design, Synthesis and Pharmacology of Cannabimimetic Indoles
-
Huffman, J.W.; Dong, D. Design, Synthesis and Pharmacology of Cannabimimetic Indoles. Bioorg. Med. Chem. Lett., 1994, 4(4), 563-566
-
(1994)
Bioorg. Med. Chem. Lett.
, vol.4
, Issue.4
, pp. 563-566
-
-
Huffman, J.W.1
Dong, D.2
-
187
-
-
0026969158
-
Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol
-
Compton, D.R.; Gold, L.H.; Ward, S.J.; Balster, R.L.; Martin, B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 1992, 263(3), 1118-1126
-
(1992)
J. Pharmacol. Exp. Ther.
, vol.263
, Issue.3
, pp. 1118-1126
-
-
Compton, D.R.1
Gold, L.H.2
Ward, S.J.3
Balster, R.L.4
Martin, B.R.5
-
188
-
-
0029081885
-
Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens
-
Pertwee, R.G.; Griffin, G.; Lainton, J.A.H.; Huffman, J.W. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol., 1995, 284, 241-247
-
(1995)
Eur. J. Pharmacol.
, vol.284
, pp. 241-247
-
-
Pertwee, R.G.1
Griffin, G.2
Lainton, J.A.H.3
Huffman, J.W.4
-
189
-
-
0031864382
-
Structure-activity relationships of indole and pyrrole-derived cannabinoids
-
Wiley, J.L.; Compton, D.R.; Dai, D.; Huffman, J.W.; Martin, B.R. Structure-activity relationships of indole and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther., 1998, 285, 994-1004
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.285
, pp. 994-1004
-
-
Wiley, J.L.1
Compton, D.R.2
Dai, D.3
Huffman, J.W.4
Martin, B.R.5
-
190
-
-
0012872233
-
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding
-
Aung, M.M.; Griffin, G.; Huffman, J.W.; Wu, M.; Keel, C.; Yang, B.; Showalter, V.M.; Abood, M.E.; Martin, B.R. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding. Drug Alcohol Depend., 2000, 60(2), 133-140
-
(2000)
Drug Alcohol Depend.
, vol.60
, Issue.2
, pp. 133-140
-
-
Aung, M.M.1
Griffin, G.2
Huffman, J.W.3
Wu, M.4
Keel, C.5
Yang, B.6
Showalter, V.M.7
Abood, M.E.8
Martin, B.R.9
-
191
-
-
29244478635
-
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
-
Ehrhart, J.; Obregon, D.; Mori, T.; Hou, H.; Sun, N.; Bai, Y.; Klein, T.; Fernandez, F.; Tan, J.; Shytle, R.D. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J. Neuroinflammation., 2005, 2, 29
-
(2005)
J. Neuroinflammation.
, vol.2
, pp. 29
-
-
Ehrhart, J.1
Obregon, D.2
Mori, T.3
Hou, H.4
Sun, N.5
Bai, Y.6
Klein, T.7
Fernandez, F.8
Tan, J.9
Shytle, R.D.10
-
192
-
-
0033661798
-
Cannabinoid receptors and the regulation of immune response
-
Berdyshev, E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 2000, 108, 169-190
-
(2000)
Chem. Phys. Lipids
, vol.108
, pp. 169-190
-
-
Berdyshev, E.V.1
-
193
-
-
14244264502
-
Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation
-
Ramirez, B.G.; Blazquez, C.; Gomez del Pulgar, T.; Guzman, M.; de Ceballos, M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci., 2005, 25(8), 1904-1913
-
(2005)
J. Neurosci.
, vol.25
, Issue.8
, pp. 1904-1913
-
-
Ramirez, B.G.1
Blazquez, C.2
Gomez Del Pulgar, T.3
Guzman, M.4
De Ceballos, M.L.5
-
194
-
-
33744827120
-
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
-
Ghosh, S.; Preet, A.; Groopman, J.E.; Ganju, R.K. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol. Immunol., 2006, 43(14), 2169-2179
-
(2006)
Mol. Immunol.
, vol.43
, Issue.14
, pp. 2169-2179
-
-
Ghosh, S.1
Preet, A.2
Groopman, J.E.3
Ganju, R.K.4
-
195
-
-
41549162387
-
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signalling pathways
-
Montecucco, F.; Burger, F.; Mach, F.; Steffens, S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signalling pathways. Am. J. Physiol. Heart Circ. Physiol., 2008, 294(3), H1145-1155
-
(2008)
Am. J. Physiol. Heart Circ. Physiol.
, vol.294
, Issue.3
-
-
Montecucco, F.1
Burger, F.2
MacH, F.3
Steffens, S.4
-
196
-
-
0037009256
-
C-3 Amido-indole cannabinoid receptor modulators
-
Hynes, J.Jr.; Leftheris, K.; Wu, H.; Pandit, C.; Chen, P.; Norris, D.J.; Chen, B.C.; Zhao, R.; Kiener, P.A.; Chen, X.; Turk, L.A.; Patil-Koota, V.; Gillooly, K.M.; Shuster, D.J.; McIntyre, K.W. C-3 Amido-indole cannabinoid receptor modulators. Bioorg. Med. Chem. Lett., 2002, 12(17), 2399-2402
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, Issue.17
, pp. 2399-2402
-
-
Hynes, Jr.J.1
Leftheris, K.2
Wu, H.3
Pandit, C.4
Chen, P.5
Norris, D.J.6
Chen, B.C.7
Zhao, R.8
Kiener, P.A.9
Chen, X.10
Turk, L.A.11
Patil-Koota, V.12
Gillooly, K.M.13
Shuster, D.J.14
McIntyre, K.W.15
-
197
-
-
0029134729
-
Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics
-
Eissenstat, M.A.; Bell, M.R.; DAmbra, T.E.; Alexander, E.J.; Daum, S.J.; Ackerman, J.H.; Gruett, M.D.; Kumar, V.; Estep, K.G.; Olefirowicz, E.M.; Wetzel, J.R.; Alexander, M.D.; Weaver, J.D.III.; Haycock, D.A.; Luttinger, D.A.; Casiano, F.M.; Chippari, S.M.; Kuster, J.E.; Stevenson, J.I.; Ward, S.J. Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics. J. Med. Chem., 1995, 38(16), 3094-3105
-
(1995)
J. Med. Chem.
, vol.38
, Issue.16
, pp. 3094-3105
-
-
Eissenstat, M.A.1
Bell, M.R.2
Dambra, T.E.3
Alexander, E.J.4
Daum, S.J.5
Ackerman, J.H.6
Gruett, M.D.7
Kumar, V.8
Estep, K.G.9
Olefirowicz, E.M.10
Wetzel, J.R.11
Alexander, M.D.12
Weaver III, J.D.13
Haycock, D.A.14
Luttinger, D.A.15
Casiano, F.M.16
Chippari, S.M.17
Kuster, J.E.18
Stevenson, J.I.19
Ward, S.J.20
more..
-
198
-
-
0037573313
-
Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties
-
Wrobleski, S.T.; Chen, P.; Hynes, J.Jr.; Lin, S.; Norris, D.J.; Pandit, C.R.; Spergel, S.; Wu, H.; Tokarski, J.S.; Chen, X.; Gillooly, K.M.; Kiener, P.A.; McIntyre, K.W.; Patil-Koota, V.; Shuster, D.J.; Turk, L.A.; Yang, G.; Leftheris, K. Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties. J. Med. Chem., 2003, 46(11), 2110-2116
-
(2003)
J. Med. Chem.
, vol.46
, Issue.11
, pp. 2110-2116
-
-
Wrobleski, S.T.1
Chen, P.2
Hynes, Jr.J.3
Lin, S.4
Norris, D.J.5
Pandit, C.R.6
Spergel, S.7
Wu, H.8
Tokarski, J.S.9
Chen, X.10
Gillooly, K.M.11
Kiener, P.A.12
McIntyre, K.W.13
Patil-Koota, V.14
Shuster, D.J.15
Turk, L.A.16
Yang, G.17
Leftheris, K.18
-
200
-
-
0041836218
-
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
-
Ibrahim, M.M.; Deng, H.; Zvonok, A.; Cockayne, D.A.; Kwan, J.; Mata, H.P.; Vanderah, T.W.; Lai, J.; Porreca, F.; Makriyannis, A.; Malan, T.P.Jr. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. USA, 2003, 100(18), 10529-10533
-
(2003)
Proc. Natl. Acad. Sci. USA
, vol.100
, Issue.18
, pp. 10529-10533
-
-
Ibrahim, M.M.1
Deng, H.2
Zvonok, A.3
Cockayne, D.A.4
Kwan, J.5
Mata, H.P.6
Vanderah, T.W.7
Lai, J.8
Porreca, F.9
Makriyannis, A.10
Malan, Jr.T.P.11
-
201
-
-
0034886018
-
CB2 cannabinoid receptor-mediated peripheral antinociception
-
Malan, T.P.Jr.; Ibrahim, M.M.; Deng, H.; Liu, Q.; Mata, H.P.; Vanderah, T.; Porreca, F.; Makriyannis, A. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain, 2001, 93(3), 239-245
-
(2001)
Pain
, vol.93
, Issue.3
, pp. 239-245
-
-
Malan, Jr.T.P.1
Ibrahim, M.M.2
Deng, H.3
Liu, Q.4
Mata, H.P.5
Vanderah, T.6
Porreca, F.7
Makriyannis, A.8
-
202
-
-
38349119715
-
Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain
-
Guindon, J.; Hohmann, A.G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. B r. J. Pharmacol., 2008, 153(2), 319-334.
-
(2008)
B R. J. Pharmacol.
, vol.153
, Issue.2
, pp. 319-334
-
-
Guindon, J.1
Hohmann, A.G.2
-
203
-
-
33748490903
-
Vitro pharmacological characterization of AM1241: A protean agonist at the cannabinoid CB2 receptor?
-
Yao, B.B.; Mukherjee, S.; Fan, Y.; Garrison, T.R.; Daza, A.V.; Grayson, G.K.; Hooker, B.A.; Dart, M.J.; Sullivan, J.P.; Meyer, M.D. In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? Br. J. Pharmacol., 2006, 149(2), 145-154
-
(2006)
Br. J. Pharmacol.
, vol.149
, Issue.2
, pp. 145-154
-
-
Yao, B.B.1
Mukherjee, S.2
Fan, Y.3
Garrison, T.R.4
Daza, A.V.5
Grayson, G.K.6
Hooker, B.A.7
Dart, M.J.8
Sullivan, J.P.9
Meyer, M.D.10
-
204
-
-
33746261289
-
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
-
Kim, K.; Moore, D.H.; Makriyannis, A.; Abood, M.E. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur. J. Pharmacol., 2006, 542(1-3), 100-105
-
(2006)
Eur. J. Pharmacol.
, vol.542
, Issue.1-3
, pp. 100-105
-
-
Kim, K.1
Moore, D.H.2
Makriyannis, A.3
Abood, M.E.4
-
205
-
-
33947278309
-
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
-
Shoemaker, J.L.; Seely, K.A.; Reed, R.L.; Crow, J.P.; Prather, P.L. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. J. Neurochem., 2007, 101(1), 87-98
-
(2007)
J. Neurochem.
, vol.101
, Issue.1
, pp. 87-98
-
-
Shoemaker, J.L.1
Seely, K.A.2
Reed, R.L.3
Crow, J.P.4
Prather, P.L.5
-
206
-
-
70349128141
-
Cannabinoid-1 receptor inverse agonists: Current understanding of mechanism of action and unanswered questions
-
Fong, T.M.; Heymsfield, S.B. Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions. Int. J. Obes. (Lond.), 2009, 33(9), 947-955
-
(2009)
Int. J. Obes. (Lond.)
, vol.33
, Issue.9
, pp. 947-955
-
-
Fong, T.M.1
Heymsfield, S.B.2
-
207
-
-
1842832439
-
Tricyclic pyrazoles. Part 1. Synthesis and biological evaluation of novel 1, 4-dihydroindeno[1, 2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors
-
Mussinu, J.M.; Ruiu, S.; Mulé, A.C.; Pau, A.; Carai, M.A.M.; Loriga, G.; Murineddu, G.; Pinna, G.A. Tricyclic pyrazoles. Part 1. Synthesis and biological evaluation of novel 1, 4-dihydroindeno[1, 2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors. Bioorg. Med. Chem., 2003, 11, 251-263
-
(2003)
Bioorg. Med. Chem.
, vol.11
, pp. 251-263
-
-
Mussinu, J.M.1
Ruiu, S.2
Mulé, A.C.3
Pau, A.4
Carai, M.A.M.5
Loriga, G.6
Murineddu, G.7
Pinna, G.A.8
-
208
-
-
16244420759
-
Tricyclic pyrazoles. Part 2. Synthesis and biological evaluation of novel 4, 5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors
-
Murineddu, G.; Ruiu, S.; Mussinu, J.M.; Loriga, G.; Grella, G.E.; Carai, M.A.M.; Lazzari, P.; Pani, L.; Pinna, G.A. Tricyclic pyrazoles. Part 2. Synthesis and biological evaluation of novel 4, 5-dihydro-1H-benzo[g]indazole- based ligands for cannabinoid receptors. Bioorg. Med. Chem., 2005, 13, 3309-3320
-
(2005)
Bioorg. Med. Chem.
, vol.13
, pp. 3309-3320
-
-
Murineddu, G.1
Ruiu, S.2
Mussinu, J.M.3
Loriga, G.4
Grella, G.E.5
Carai, M.A.M.6
Lazzari, P.7
Pani, L.8
Pinna, G.A.9
-
209
-
-
84863739654
-
-
WO 01 32, 663
-
Barth, F.; Congy, C.; Martinez, S.; Rinaldi, M. Preparation and formulation of tricyclic heterocycles containing a pyrazole-3-carboxamide subunit for pharmaceutical use as cannabinoid receptor antagonists. WO 01 32, 663, 2001
-
(2001)
Preparation and Formulation of Tricyclic Heterocycles Containing A pyrazole-3-carboxamide Subunit for Pharmaceutical Use As Cannabinoid Receptor Antagonists
-
-
Barth, F.1
Congy, C.2
Martinez, S.3
Rinaldi, M.4
-
210
-
-
28544446066
-
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2', 4'-dichlorophenyl)-N-piperidin-1-yl-1, 4, 5, 6-tetrahydrobenzo[6, 7]cyclohepta[1, 2-c]pyrazole-3-carboxamide
-
Murineddu, G.; Ruiu, S.; Loriga, G.; Manca, I.; Lazzari, P.; Reali, R.; Pani, L.; Toma, L.; Pinna, G.A. Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2', 4'-dichlorophenyl)-N-piperidin-1-yl-1, 4, 5, 6-tetrahydrobenzo[6, 7]cyclohepta[1, 2-c]pyrazole-3-carboxamide. J. Med. Chem., 2005, 48(23), 7351-7362
-
(2005)
J. Med. Chem.
, vol.48
, Issue.23
, pp. 7351-7362
-
-
Murineddu, G.1
Ruiu, S.2
Loriga, G.3
Manca, I.4
Lazzari, P.5
Reali, R.6
Pani, L.7
Toma, L.8
Pinna, G.A.9
-
211
-
-
33845496711
-
Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2', 4'-dichlorophenyl)-6- methyl-N-piperidin-1-yl-1, 4-dihydroindeno[1, 2-c]pyrazole-3-carboxamide
-
Murineddu, G.; Lazzari, P.; Ruiu, S.; Sanna, A.; Loriga, G.; Manca, I.; Falzoi, M.; Dessì, C.; Curzu, M.M.; Chelucci, G.; Pani, L.; Pinna, G.A. Tricyclic pyrazoles. 4. Synthesis and biological evaluation of analogues of the robust and selective CB2 cannabinoid ligand 1-(2', 4'-dichlorophenyl)-6-methyl- N-piperidin-1-yl-1, 4-dihydroindeno[1, 2-c]pyrazole-3-carboxamide. J. Med. Chem., 2006, 49(25), 7502-7512
-
(2006)
J. Med. Chem.
, vol.49
, Issue.25
, pp. 7502-7512
-
-
Murineddu, G.1
Lazzari, P.2
Ruiu, S.3
Sanna, A.4
Loriga, G.5
Manca, I.6
Falzoi, M.7
Dessì, C.8
Curzu, M.M.9
Chelucci, G.10
Pani, L.11
Pinna, G.A.12
-
212
-
-
77955981912
-
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS
-
Gorantla, S.; Makarov, E.; Roy, D.; Finke-Dwyer, J.; Murrin, L.C.; Gendelman, H.E.; Poluektova, L. Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS. J. Neuroimmune Pharmacol., 2010, 5(3), 456-468
-
(2010)
J. Neuroimmune Pharmacol.
, vol.5
, Issue.3
, pp. 456-468
-
-
Gorantla, S.1
Makarov, E.2
Roy, D.3
Finke-Dwyer, J.4
Murrin, L.C.5
Gendelman, H.E.6
Poluektova, L.7
-
213
-
-
84880870111
-
-
WO/2004/060882, July 22, 2004
-
Leung, C.; Tomaszewski, M.; Woo, S. CB 1/CB 2 receptor ligands and their use in the treatment of pain. WO/2004/060882, July 22, 2004
-
CB 1/CB 2 Receptor Ligands and Their Use in the Treatment of Pain
-
-
Leung, C.1
Tomaszewski, M.2
Woo, S.3
-
214
-
-
61349106086
-
Morpholine containing CB2 selective agonists
-
Zindell, R.; Riether, D.; Bosanac, T.; Berry, A.; Gemkow, M.J.; Ebneth, A.; Löbbe, S.; Raymond, E.L.; Thome, D.; Shih, D.T.; Thomson, D. Morpholine containing CB2 selective agonists. Bioorg. Med. Chem. Lett., 2009, 19(6), 1604-1609
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, Issue.6
, pp. 1604-1609
-
-
Zindell, R.1
Riether, D.2
Bosanac, T.3
Berry, A.4
Gemkow, M.J.5
Ebneth, A.6
Löbbe, S.7
Raymond, E.L.8
Thome, D.9
Shih, D.T.10
Thomson, D.11
-
215
-
-
0034618541
-
Privileged molecules for protein binding identified from NMR-based screening
-
Hajduk, P.J.; Bures, M.; Praestgaard, J.; Fesik, S.W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem., 2000, 43(18), 3443-3447
-
(2000)
J. Med. Chem.
, vol.43
, Issue.18
, pp. 3443-3447
-
-
Hajduk, P.J.1
Bures, M.2
Praestgaard, J.3
Fesik, S.W.4
-
216
-
-
30444443786
-
Novel 4-oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: Synthesis, pharmacological properties and molecular modeling
-
Stern, E.; Muccioli, G.G.; Millet, R.; Goossens, J.F.; Farce, A.; Chavatte, P.; Poupaert, J.H.; Lambert, D.M.; Depreux, P.; Hénichart, J.P. Novel 4-oxo-1, 4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling. J. Med. Chem., 2006, 49(1), 70-79
-
(2006)
J. Med. Chem.
, vol.49
, Issue.1
, pp. 70-79
-
-
Stern, E.1
Muccioli, G.G.2
Millet, R.3
Goossens, J.F.4
Farce, A.5
Chavatte, P.6
Poupaert, J.H.7
Lambert, D.M.8
Depreux, P.9
Hénichart, J.P.10
-
217
-
-
35848957071
-
Pharmacomodulations around the 4-Oxo-1, 4-dihydroquinoline-3- carboxamides, a Class of Potent CB2-Selective Cannabinoid Receptor Ligands: Consequences in Receptor Affinity and Functionality
-
Stern, E.; Muccioli, G.G.; Bosier, B.; Hamtiaux, L.; Millet, R.; Poupaert, J.H.; Hénichart, J.P.; Depreux, P.; Goossens, J.-F.; Lambert, D.M. Pharmacomodulations around the 4-Oxo-1, 4-dihydroquinoline-3-carboxamides, a Class of Potent CB2-Selective Cannabinoid Receptor Ligands: Consequences in Receptor Affinity and Functionality. J. Med. Chem., 2007, 50(22), 5471-5484
-
(2007)
J. Med. Chem.
, vol.50
, Issue.22
, pp. 5471-5484
-
-
Stern, E.1
Muccioli, G.G.2
Bosier, B.3
Hamtiaux, L.4
Millet, R.5
Poupaert, J.H.6
Hénichart, J.P.7
Depreux, P.8
Goossens, J.-F.9
Lambert, D.M.10
-
218
-
-
78649506916
-
4-Oxo-1, 4-Dihydroquinoline-3-Carboxamides Derivatives As New Potent and Selective Cb2 Agonists with Anti-Inflammatory and Analgesic Properties in the Gut
-
Body-Malapel, M.; El-Bakali, J.; Mérour, E.; Stern, E.; Millet, R.; Desreumaux, P. 4-Oxo-1, 4-Dihydroquinoline-3-Carboxamides Derivatives As New Potent and Selective Cb2 Agonists with Anti-Inflammatory and Analgesic Properties in the Gut. Gastroenterology, 2008, 134(4, Suppl 1), A-107
-
(2008)
Gastroenterology
, vol.134
, Issue.4 SUPPL. 1
-
-
Body-Malapel, M.1
El-Bakali, J.2
Mérour, E.3
Stern, E.4
Millet, R.5
Desreumaux, P.6
-
219
-
-
78649497663
-
4-Oxo-1, 4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands: Structural Insights into the Design of a Novel Inverse Agonist Series
-
El Bakali, J.; Muccioli, G.G.; Renault, N.; Pradal, D.; Body-Malapel, M.; Djouina, M.; Hamtiaux, L.; Andrzejak, V.; Desreumaux, P.; Chavatte, P.; Lambert, D.M.; Millet, R. 4-Oxo-1, 4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands: Structural Insights into the Design of a Novel Inverse Agonist Series. J. Med. Chem., 2010, 53(22), 7918-7931
-
(2010)
J. Med. Chem.
, vol.53
, Issue.22
, pp. 7918-7931
-
-
El Bakali, J.1
Muccioli, G.G.2
Renault, N.3
Pradal, D.4
Body-Malapel, M.5
Djouina, M.6
Hamtiaux, L.7
Andrzejak, V.8
Desreumaux, P.9
Chavatte, P.10
Lambert, D.M.11
Millet, R.12
-
220
-
-
84863734249
-
-
Eur. Patent EP-092903377.2-1211, May 20
-
Millet, R.; El Bakali, J.; Body-Malapel, M.; Renault, N.; Muccioli, G.G.; Chavatte, P.; Desreumaux, P.; Lambert, D.M. 1, 4-Dihydropyridines derivatives and their uses. Eur. Patent EP-092903377.2-1211, May 20, 2009
-
(2009)
1, 4-Dihydropyridines Derivatives and Their Uses
-
-
Millet, R.1
El Bakali, J.2
Body-Malapel, M.3
Renault, N.4
Muccioli, G.G.5
Chavatte, P.6
Desreumaux, P.7
Lambert, D.M.8
-
221
-
-
84863734249
-
-
Int. Patent PCT/IB2010/001433, May 9
-
Millet, R.; El Bakali, J.; Body-Malapel, M.; Renault, N.; Muccioli, G.G.; Chavatte, P.; Desreumaux, P.; Lambert, D.M. 1, 4-Dihydropyridines derivatives and their uses. Int. Patent PCT/IB2010/001433, May 9, 2010.
-
(2010)
1, 4-Dihydropyridines Derivatives and Their Uses
-
-
Millet, R.1
El Bakali, J.2
Body-Malapel, M.3
Renault, N.4
Muccioli, G.G.5
Chavatte, P.6
Desreumaux, P.7
Lambert, D.M.8
|